G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet. 1993r;52(3):551–6. PMID: 8447321","Мазунин И.О., Володько Н.В., Стариковская Е.Б., Сукерник Р.И. Митохондриальный геном и митохондриальные заболевания человека. Молекулярная биология. 2010;44(5):755–72.","Celentano V., Esposito E., Perrotta S., Giglio M.C., Tarquini R., Luglio G., et al. Madelung disease: report of a case and review of the literature. Acta Chir Belg. 2014;114(6):417–20. PMID: 26021689","Lemaitre M., Chevalier B., Jannin A., Bourry J., Espiard S., Vantyghem M.C. Multiple symmetric and multiple familial lipomatosis. Presse Med. 2021;50(3):104077. DOI: 10.1016/j.lpm.2021.104077","Вецмадян Е.А., Труфанов Г.Е., Рязанов В.В., Мостовая О.Т., Новиков К.В., Карайванов Н.С. Ультразвуковая диагностика липом мягких тканей с использованием методик цветного допплеровского картирования и эластографии. Вестник Российской Военно-медицинской академии. 2012;2(38):43–50.","Богов А.А., Андреев П.С., Филиппов В.Л., Топыркин В.Г. Оперативное лечение болезни Маделунга. Практическая медицина. 2018;16(7-1):90–3.","Уракова Е.В., Нестеров О.В., Ильина Р.Ю., Лексин Р.В. Хирургическая тактика при рецидивирующем липоматозе (болезни Маделунга). Клинический случай. Практическая медицина. 2022;20(6):131–3.","Егай А.А., Тентимишев А.Э., Норматов Р.М., Тян А.С. Хирургическое лечение множественного симметричного липоматоза (болезнь Маделунга), осложненного сдавлением яремных вен с обеих сторон. Преимущества липэктомии перед липосакцией. Научное обозрение. Медицинские науки. 2022;1:5– 10. DOI: 10.17513/srms.1225","Тимербулатов М.В., Шорнина А.С., Лихтер Р.А., Каипов А.Э. Оценка липосакции в структуре абдоминопластики и сочетанной герниоабдоминопластики. Креативная хирургия и онкология. 2023;13(4):278–83. DOI: 10.24060/2076-3093-2023-13-4-278-283","Dang Y., Du X., Ou X., Zheng Q., Xie F. Advances in diagnosis and treatment of Madelung’s deformity. Am J Transl Res. 2023;15(7):4416–24.","Leti Acciaro A, Garagnani L, Lando M, Lana D, Sartini S, Adani R. Modified dome osteotomy and anterior locking plate fixation for distal radius variant of Madelung deformity: a retrospective study. J Plast Surg Hand Surg. 2022;56(2):121–6. DOI: 10.1080/2000656X.2021.1934845","Liu Q., Lyu H., Xu B., Lee J.H. Madelung disease epidemiology and clinical characteristics: a systemic review. Aesthetic Plast Surg. 2021;45(3):977–86. DOI: 10.1007/s00266-020-02083-5","Sia K.J., Tang I.P., Tan T.Y. Multiple symmetrical lipomatosis: case report and literature review. J Laryngol Otol. 2012;126(7):756–8. DOI: 10.1017/S0022215112000709","Kratz C., Lenard H.G., Ruzicka T., Gärtner J. Multiple symmetric lipomatosis: an unusual cause of childhood obesity and mental retardation. Eur J Paediatr Neurol. 2000;4(2):63–7. DOI: 10.1053/ejpn.2000.0264","Nounla J., Rolle U., Gräfe G., Kräling K. Benign symmetric lipomatosis with myelomeningocele in an adolescent: An uncommon association-case report. J Pediatr Surg. 2001;36(7):E13. DOI: 10.1053/jpsu.2001.24776","Madelung O.W. Über den Fetthals (diffuses Lipom des Halses). Arch Klin Chir. 1888;37:106-30.","Lanois P.E., Bensaude R. De ladeno-lipomatosesymetrique. Bull Mem Soc Med Hosp. 1898;1:298.","El Ouahabi H., Doubi S., Lahlou K., Boujraf S., Ajdi F. Launois-bensaude syndrome: A benign symmetric lipomatosis without alcohol association. Ann Afr Med. 2017;16(1):33–4. DOI: 10.4103/1596-3519.202082","Chen C.Y., Fang Q.Q., Wang X.F., Zhang M.X., Zhao W.Y., Shi B.H., et al. Madelung’s disease: lipectomy or liposuction? Biomed Res Int. 2018;3975974. DOI: 10.1155/2018/3975974","Coker J.E., Bryan J.A. Endocrine and metabolic disorders: Causes and pathogenesis of obesity. J. Fam. Pract. 2008;4:21–6.","González-García R., Rodríguez-Campo F.J., Sastre-Pérez J., Muñoz-Guerra M.F. Benign symmetric lipomatosis (Madelung’s disease): case reports and current management. Aesthetic Plast Surg. 2004;28(2):108– 12; discussion 113. DOI: 10.1007/s00266-004-3123-5","Holme E., Larsson N.G., Oldfors A., Tulinius M., Sahlin P., Stenman G. Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A-->G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet. 1993r;52(3):551–6. PMID: 8447321","Мазунин И.О., Володько Н.В., Стариковская Е.Б., Сукерник Р.И. Митохондриальный геном и митохондриальные заболевания человека. Молекулярная биология. 2010;44(5):755–72.","Celentano V., Esposito E., Perrotta S., Giglio M.C., Tarquini R., Luglio G., et al. Madelung disease: report of a case and review of the literature. Acta Chir Belg. 2014;114(6):417–20. PMID: 26021689","Lemaitre M., Chevalier B., Jannin A., Bourry J., Espiard S., Vantyghem M.C. Multiple symmetric and multiple familial lipomatosis. Presse Med. 2021;50(3):104077. DOI: 10.1016/j.lpm.2021.104077","Вецмадян Е.А., Труфанов Г.Е., Рязанов В.В., Мостовая О.Т., Новиков К.В., Карайванов Н.С. Ультразвуковая диагностика липом мягких тканей с использованием методик цветного допплеровского картирования и эластографии. Вестник Российской Военно-медицинской академии. 2012;2(38):43–50.","Богов А.А., Андреев П.С., Филиппов В.Л., Топыркин В.Г. Оперативное лечение болезни Маделунга. Практическая медицина. 2018;16(7-1):90–3.","Уракова Е.В., Нестеров О.В., Ильина Р.Ю., Лексин Р.В. Хирургическая тактика при рецидивирующем липоматозе (болезни Маделунга). Клинический случай. Практическая медицина. 2022;20(6):131–3.","Егай А.А., Тентимишев А.Э., Норматов Р.М., Тян А.С. Хирургическое лечение множественного симметричного липоматоза (болезнь Маделунга), осложненного сдавлением яремных вен с обеих сторон. Преимущества липэктомии перед липосакцией. Научное обозрение. Медицинские науки. 2022;1:5– 10. DOI: 10.17513/srms.1225","Тимербулатов М.В., Шорнина А.С., Лихтер Р.А., Каипов А.Э. Оценка липосакции в структуре абдоминопластики и сочетанной герниоабдоминопластики. Креативная хирургия и онкология. 2023;13(4):278–83. DOI: 10.24060/2076-3093-2023-13-4-278-283","Dang Y., Du X., Ou X., Zheng Q., Xie F. Advances in diagnosis and treatment of Madelung’s deformity. Am J Transl Res. 2023;15(7):4416–24.","Leti Acciaro A, Garagnani L, Lando M, Lana D, Sartini S, Adani R. Modified dome osteotomy and anterior locking plate fixation for distal radius variant of Madelung deformity: a retrospective study. J Plast Surg Hand Surg. 2022;56(2):121–6. DOI: 10.1080/2000656X.2021.1934845"],"dc.citation.ru":["Liu Q., Lyu H., Xu B., Lee J.H. Madelung disease epidemiology and clinical characteristics: a systemic review. Aesthetic Plast Surg. 2021;45(3):977–86. DOI: 10.1007/s00266-020-02083-5","Sia K.J., Tang I.P., Tan T.Y. Multiple symmetrical lipomatosis: case report and literature review. J Laryngol Otol. 2012;126(7):756–8. DOI: 10.1017/S0022215112000709","Kratz C., Lenard H.G., Ruzicka T., Gärtner J. Multiple symmetric lipomatosis: an unusual cause of childhood obesity and mental retardation. Eur J Paediatr Neurol. 2000;4(2):63–7. DOI: 10.1053/ejpn.2000.0264","Nounla J., Rolle U., Gräfe G., Kräling K. Benign symmetric lipomatosis with myelomeningocele in an adolescent: An uncommon association-case report. J Pediatr Surg. 2001;36(7):E13. DOI: 10.1053/jpsu.2001.24776","Madelung O.W. Über den Fetthals (diffuses Lipom des Halses). Arch Klin Chir. 1888;37:106-30.","Lanois P.E., Bensaude R. De ladeno-lipomatosesymetrique. Bull Mem Soc Med Hosp. 1898;1:298.","El Ouahabi H., Doubi S., Lahlou K., Boujraf S., Ajdi F. Launois-bensaude syndrome: A benign symmetric lipomatosis without alcohol association. Ann Afr Med. 2017;16(1):33–4. DOI: 10.4103/1596-3519.202082","Chen C.Y., Fang Q.Q., Wang X.F., Zhang M.X., Zhao W.Y., Shi B.H., et al. Madelung’s disease: lipectomy or liposuction? Biomed Res Int. 2018;3975974. DOI: 10.1155/2018/3975974","Coker J.E., Bryan J.A. Endocrine and metabolic disorders: Causes and pathogenesis of obesity. J. Fam. Pract. 2008;4:21–6.","González-García R., Rodríguez-Campo F.J., Sastre-Pérez J., Muñoz-Guerra M.F. Benign symmetric lipomatosis (Madelung’s disease): case reports and current management. Aesthetic Plast Surg. 2004;28(2):108– 12; discussion 113. DOI: 10.1007/s00266-004-3123-5","Holme E., Larsson N.G., Oldfors A., Tulinius M., Sahlin P., Stenman G. Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A-->G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet. 1993r;52(3):551–6. PMID: 8447321","Мазунин И.О., Володько Н.В., Стариковская Е.Б., Сукерник Р.И. Митохондриальный геном и митохондриальные заболевания человека. Молекулярная биология. 2010;44(5):755–72.","Celentano V., Esposito E., Perrotta S., Giglio M.C., Tarquini R., Luglio G., et al. Madelung disease: report of a case and review of the literature. Acta Chir Belg. 2014;114(6):417–20. PMID: 26021689","Lemaitre M., Chevalier B., Jannin A., Bourry J., Espiard S., Vantyghem M.C. Multiple symmetric and multiple familial lipomatosis. Presse Med. 2021;50(3):104077. DOI: 10.1016/j.lpm.2021.104077","Вецмадян Е.А., Труфанов Г.Е., Рязанов В.В., Мостовая О.Т., Новиков К.В., Карайванов Н.С. Ультразвуковая диагностика липом мягких тканей с использованием методик цветного допплеровского картирования и эластографии. Вестник Российской Военно-медицинской академии. 2012;2(38):43–50.","Богов А.А., Андреев П.С., Филиппов В.Л., Топыркин В.Г. Оперативное лечение болезни Маделунга. Практическая медицина. 2018;16(7-1):90–3.","Уракова Е.В., Нестеров О.В., Ильина Р.Ю., Лексин Р.В. Хирургическая тактика при рецидивирующем липоматозе (болезни Маделунга). Клинический случай. Практическая медицина. 2022;20(6):131–3.","Егай А.А., Тентимишев А.Э., Норматов Р.М., Тян А.С. Хирургическое лечение множественного симметричного липоматоза (болезнь Маделунга), осложненного сдавлением яремных вен с обеих сторон. Преимущества липэктомии перед липосакцией. Научное обозрение. Медицинские науки. 2022;1:5– 10. DOI: 10.17513/srms.1225","Тимербулатов М.В., Шорнина А.С., Лихтер Р.А., Каипов А.Э. Оценка липосакции в структуре абдоминопластики и сочетанной герниоабдоминопластики. Креативная хирургия и онкология. 2023;13(4):278–83. DOI: 10.24060/2076-3093-2023-13-4-278-283","Dang Y., Du X., Ou X., Zheng Q., Xie F. Advances in diagnosis and treatment of Madelung’s deformity. Am J Transl Res. 2023;15(7):4416–24.","Leti Acciaro A, Garagnani L, Lando M, Lana D, Sartini S, Adani R. Modified dome osteotomy and anterior locking plate fixation for distal radius variant of Madelung deformity: a retrospective study. J Plast Surg Hand Surg. 2022;56(2):121–6. DOI: 10.1080/2000656X.2021.1934845"],"dc.citation.en":["Liu Q., Lyu H., Xu B., Lee J.H. Madelung disease epidemiology and clinical characteristics: a systemic review. Aesthetic Plast Surg. 2021;45(3):977–86. DOI: 10.1007/s00266-020-02083-5","Sia K.J., Tang I.P., Tan T.Y. Multiple symmetrical lipomatosis: case report and literature review. J Laryngol Otol. 2012;126(7):756–8. DOI: 10.1017/S0022215112000709","Kratz C., Lenard H.G., Ruzicka T., Gärtner J. Multiple symmetric lipomatosis: an unusual cause of childhood obesity and mental retardation. Eur J Paediatr Neurol. 2000;4(2):63–7. DOI: 10.1053/ejpn.2000.0264","Nounla J., Rolle U., Gräfe G., Kräling K. Benign symmetric lipomatosis with myelomeningocele in an adolescent: An uncommon association-case report. J Pediatr Surg. 2001;36(7):E13. DOI: 10.1053/jpsu.2001.24776","Madelung O.W. Über den Fetthals (diffuses Lipom des Halses). Arch Klin Chir. 1888;37:106-30.","Lanois P.E., Bensaude R. De ladeno-lipomatosesymetrique. Bull Mem Soc Med Hosp. 1898;1:298.","El Ouahabi H., Doubi S., Lahlou K., Boujraf S., Ajdi F. Launois-bensaude syndrome: A benign symmetric lipomatosis without alcohol association. Ann Afr Med. 2017;16(1):33–4. DOI: 10.4103/1596-3519.202082","Chen C.Y., Fang Q.Q., Wang X.F., Zhang M.X., Zhao W.Y., Shi B.H., et al. Madelung’s disease: lipectomy or liposuction? Biomed Res Int. 2018;3975974. DOI: 10.1155/2018/3975974","Coker J.E., Bryan J.A. Endocrine and metabolic disorders: Causes and pathogenesis of obesity. J. Fam. Pract. 2008;4:21–6.","González-García R., Rodríguez-Campo F.J., Sastre-Pérez J., Muñoz-Guerra M.F. Benign symmetric lipomatosis (Madelung’s disease): case reports and current management. Aesthetic Plast Surg. 2004;28(2):108– 12; discussion 113. DOI: 10.1007/s00266-004-3123-5","Holme E., Larsson N.G., Oldfors A., Tulinius M., Sahlin P., Stenman G. Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A-->G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet. 1993r;52(3):551–6. PMID: 8447321","Мазунин И.О., Володько Н.В., Стариковская Е.Б., Сукерник Р.И. Митохондриальный геном и митохондриальные заболевания человека. Молекулярная биология. 2010;44(5):755–72.","Celentano V., Esposito E., Perrotta S., Giglio M.C., Tarquini R., Luglio G., et al. Madelung disease: report of a case and review of the literature. Acta Chir Belg. 2014;114(6):417–20. PMID: 26021689","Lemaitre M., Chevalier B., Jannin A., Bourry J., Espiard S., Vantyghem M.C. Multiple symmetric and multiple familial lipomatosis. Presse Med. 2021;50(3):104077. DOI: 10.1016/j.lpm.2021.104077","Вецмадян Е.А., Труфанов Г.Е., Рязанов В.В., Мостовая О.Т., Новиков К.В., Карайванов Н.С. Ультразвуковая диагностика липом мягких тканей с использованием методик цветного допплеровского картирования и эластографии. Вестник Российской Военно-медицинской академии. 2012;2(38):43–50.","Богов А.А., Андреев П.С., Филиппов В.Л., Топыркин В.Г. Оперативное лечение болезни Маделунга. Практическая медицина. 2018;16(7-1):90–3.","Уракова Е.В., Нестеров О.В., Ильина Р.Ю., Лексин Р.В. Хирургическая тактика при рецидивирующем липоматозе (болезни Маделунга). Клинический случай. Практическая медицина. 2022;20(6):131–3.","Егай А.А., Тентимишев А.Э., Норматов Р.М., Тян А.С. Хирургическое лечение множественного симметричного липоматоза (болезнь Маделунга), осложненного сдавлением яремных вен с обеих сторон. Преимущества липэктомии перед липосакцией. Научное обозрение. Медицинские науки. 2022;1:5– 10. DOI: 10.17513/srms.1225","Тимербулатов М.В., Шорнина А.С., Лихтер Р.А., Каипов А.Э. Оценка липосакции в структуре абдоминопластики и сочетанной герниоабдоминопластики. Креативная хирургия и онкология. 2023;13(4):278–83. DOI: 10.24060/2076-3093-2023-13-4-278-283","Dang Y., Du X., Ou X., Zheng Q., Xie F. Advances in diagnosis and treatment of Madelung’s deformity. Am J Transl Res. 2023;15(7):4416–24.","Leti Acciaro A, Garagnani L, Lando M, Lana D, Sartini S, Adani R. Modified dome osteotomy and anterior locking plate fixation for distal radius variant of Madelung deformity: a retrospective study. J Plast Surg Hand Surg. 2022;56(2):121–6. DOI: 10.1080/2000656X.2021.1934845"],"dc.identifier.uri":["http://hdl.handle.net/123456789/8932"],"dc.date.accessioned_dt":"2025-07-09T13:59:02Z","dc.date.accessioned":["2025-07-09T13:59:02Z"],"dc.date.available":["2025-07-09T13:59:02Z"],"publication_grp":["123456789/8932"],"bi_4_dis_filter":["madelung’s disease\n|||\nMadelung’s disease","lipectomy\n|||\nlipectomy","диффузный симметричный липоматоз\n|||\nдиффузный симметричный липоматоз","шеи новообразования\n|||\nшеи новообразования","липэктомия\n|||\nлипэктомия","diffuse symmetric lipomatosis\n|||\ndiffuse symmetric lipomatosis","adipose tissue proliferation\n|||\nadipose tissue proliferation","жировой ткани разрастание\n|||\nжировой ткани разрастание","болезнь маделунга\n|||\nболезнь Маделунга","neck neoplasms\n|||\nneck neoplasms"],"bi_4_dis_partial":["липэктомия","Madelung’s disease","diffuse symmetric lipomatosis","neck neoplasms","болезнь Маделунга","adipose tissue proliferation","шеи новообразования","lipectomy","диффузный симметричный липоматоз","жировой ткани разрастание"],"bi_4_dis_value_filter":["липэктомия","Madelung’s disease","diffuse symmetric lipomatosis","neck neoplasms","болезнь Маделунга","adipose tissue proliferation","шеи новообразования","lipectomy","диффузный симметричный липоматоз","жировой ткани разрастание"],"bi_sort_1_sort":"systemic benign lipomatosis (madelung’s disease): experience of surgical treatment. clinical case","bi_sort_3_sort":"2025-07-09T13:59:02Z","read":["g0"],"_version_":1837178072511545344},{"SolrIndexer.lastIndexed":"2021-04-20T11:27:23.865Z","search.uniqueid":"2-4548","search.resourcetype":2,"search.resourceid":4548,"handle":"123456789/5453","location":["m195","l691"],"location.comm":["195"],"location.coll":["691"],"withdrawn":"false","discoverable":"true","dc.date.accessioned_dt":"2021-01-14T11:51:30Z","dc.date.accessioned":["2021-01-14T11:51:30Z"],"dc.date.available":["2021-01-14T11:51:30Z"],"dc.identifier.uri":["http://hdl.handle.net/123456789/5453"],"dc.rights":["CC BY 4.0"],"dc.source":["Bashkortostan Medical Journal","Медицинский вестник Башкортостана"],"dc.source.en":["Bashkortostan Medical Journal"],"dc.source.ru":["Медицинский вестник Башкортостана"],"subject":["внутриглазное давление","глаукома","стресс","психоэмоциональное состояние","маркеры","intraocular pressure","glaucoma","stress","psycho-emotional state","markers"],"subject_keyword":["внутриглазное давление","внутриглазное давление","глаукома","глаукома","стресс","стресс","психоэмоциональное состояние","психоэмоциональное состояние","маркеры","маркеры","intraocular pressure","intraocular pressure","glaucoma","glaucoma","stress","stress","psycho-emotional state","psycho-emotional state","markers","markers"],"subject_ac":["внутриглазное давление\n|||\nвнутриглазное давление","глаукома\n|||\nглаукома","стресс\n|||\nстресс","психоэмоциональное состояние\n|||\nпсихоэмоциональное состояние","маркеры\n|||\nмаркеры","intraocular pressure\n|||\nintraocular pressure","glaucoma\n|||\nglaucoma","stress\n|||\nstress","psycho-emotional state\n|||\npsycho-emotional state","markers\n|||\nmarkers"],"subject_tax_0_filter":["внутриглазное давление\n|||\nвнутриглазное давление","глаукома\n|||\nглаукома","стресс\n|||\nстресс","психоэмоциональное состояние\n|||\nпсихоэмоциональное состояние","маркеры\n|||\nмаркеры","intraocular pressure\n|||\nintraocular pressure","glaucoma\n|||\nglaucoma","stress\n|||\nstress","psycho-emotional state\n|||\npsycho-emotional state","markers\n|||\nmarkers"],"subject_filter":["внутриглазное давление\n|||\nвнутриглазное давление","глаукома\n|||\nглаукома","стресс\n|||\nстресс","психоэмоциональное состояние\n|||\nпсихоэмоциональное состояние","маркеры\n|||\nмаркеры","intraocular pressure\n|||\nintraocular pressure","glaucoma\n|||\nglaucoma","stress\n|||\nstress","psycho-emotional state\n|||\npsycho-emotional state","markers\n|||\nmarkers"],"dc.subject_mlt":["внутриглазное давление","глаукома","стресс","психоэмоциональное состояние","маркеры","intraocular pressure","glaucoma","stress","psycho-emotional state","markers"],"dc.subject":["внутриглазное давление","глаукома","стресс","психоэмоциональное состояние","маркеры","intraocular pressure","glaucoma","stress","psycho-emotional state","markers"],"dc.subject.ru":["внутриглазное давление","глаукома","стресс","психоэмоциональное состояние","маркеры","intraocular pressure","glaucoma","stress","psycho-emotional state","markers"],"title":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT","ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"title_keyword":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT","ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"title_ac":["stress factor in glaucoma development\n|||\nSTRESS FACTOR IN GLAUCOMA DEVELOPMENT","фактор стресса в развитии глаукомы\n|||\nФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"dc.title_sort":"STRESS FACTOR IN GLAUCOMA DEVELOPMENT","dc.title_hl":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT","ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"dc.title_mlt":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT","ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"dc.title":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT","ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"dc.title_stored":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru"],"dc.title.en":["STRESS FACTOR IN GLAUCOMA DEVELOPMENT"],"dc.title.ru":["ФАКТОР СТРЕССА В РАЗВИТИИ ГЛАУКОМЫ"],"dc.citation":["Авербах, М.И. Офтальмологические очерки / М.И. Авербах. - М., 1949. - С. 357","Алексеев, В.Н. Зависимость стабилизации зрительных функций от уровня внутриглазного давления у больных первичной открытоугольной глаукомой / В.Н. Алексеев, Т.Г. Зубкова, О.А. Малеванная // Сб. науч. тр. регион. конф. «Глаукома: теория и практика». - СПб., 2008. - С. 7-11","Басинский, С.Н. Психоэмоциональные нарушения у пациентов с глаукомой и возможности их фармакокоррекции в комплексном лечении заболевания / С.Н. Басинский, В.Н. Красногорская, А.С. Басинский, И.Н. Рогачев // Русский медицинский журнал. Клиническая офтальмольмология. - 2009. - № 4. - С.133","Бойко, Э.В. Качество жизни и психологический статус больных с глаукомой и катарактой / Э.В. Бойко, В.Н. Сысоев, А.А. Новик, О.В. Кузьмичева // Глаукома. - 2010. - № 1. - С. 21-25","Габдрахманова, А.Ф. Некоторые аспекты комплексного лечения открытоугольной глаукомы / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Медицинский вестник Башкортостана. - 2014. - Т. 9, № 2. - С. 42-45","Габдрахманова, А.Ф. Новые подходы к коррекции нарушений психологического статуса и качества жизни больных первичной открытоугольной глаукомой / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Вестник Кыргызско-Российского славянского университета. - 2013. - Т. 13, № 9. - С. 194-196","Габдрахманова, А.Ф. Первые результаты оценки качества жизни пациентов с глаукомой в Республике Башкортостан / А.Ф. Габдрахманова, С.А. Курбанов // Российский офтальмологический журнал. - 2013. - Т. 6, № 2. - С. 16-19","Гизатуллина, Е.А. Динамика зрительных функций при первичной открытоугольной глаукоме с нормализованным внутриглазным давлением у больных с различной стресс-резистентностью / Е.А.Гизатуллина, И.Г.Брындина, В.В.Жаров // Вестник Оренбургского государственного университета -2011. - № 14. - С.88-89","Егоров, Е.А. Национальное руководство по глаукоме для практикующих врачей / Е.А. Егоров, Ю.С. Астахов, В.П. Еричев. - М.: ГЭОТАР-Медиа, 2015. - 456 с","Егоров, Е.А. Национальное руководство по глаукоме / Е.А. Егоров. - М.: ГЕОТАР-Медиа, 2013. - 824 с","Изевлина, Н.Л. Психологические особенности больных с псевдоэксфолиативной глаукомой / Н.Л. Изевлина, Л.М. Габдрахманов М.В. Шевченко, Ф.С. Галеева // Ерошевские чтения - 2007. - Самара, 2007. - С. 93-95","Изевлина, Н.Л. Результаты психодиагностических исследований у больных первичной открытоугольной глаукомой / Н.Л. Изевлина, М.В. Шевченко, Т.Н. Лумпова // Материалы III Евроазиатской конф. по офтальмохирургии. - Екатеринбург, 2003.- С. 168-171","Казачкова, Л.Е. Личностные особенности больных первичной открытоугольной глаукомой / Л.Е. Казачкова, Е.В. Козина // Материалы научно-практ. конф. офтальмологов Сибири и Дальнего Востока. - Владивосток, 2000. - С. 14-16","Карвасарский, Б.Д. Психотерапия / Б.Д. Карвасарский. - СПб.: Питер, 2012. - 674 с","Козина, Е.В. Качество жизни больных первичной открытоугольной глаукомой / Е.В. Козина // Русский медицинский журнал. Клиническая офтальмология. -2003. - № 3. - С.137","Мягков, А.В. Влияние психоэмоционального стресса на внутриглазное давление и формирование офтальмогипертензии / А.В. Мягков // Казанский медицинский журнал. - 2002. - № 2.- С. 72-73","Соколов, В.А. Первичная открытоугольная глаукома: психосоматические черты болезни / В.А. Соколов, М.Н. Чернобавская // Глаукома: теории, тенденции, технологии: сб. науч. ст. - М., 2011. - С. 295-298","Depression, anxiety and disturbed sleep in glaucoma / A. Agorastos [et al.] // Journal of Neuropsychiatry and clinical neurosciences. - 2013. - Vol. 25. - P. 205-213","Aspinall, P.A. Quality of life in glaucoma and its relationship with visual function / P.A. Aspinall, Z.K. Johnson, A. Azuara-Blanco, A. Montarzino, R. Brice, A.Vickers // J. Glaucoma. - 2003. - 12(2). - P.139-50","Benoist, D. C. Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis. / C.D. Benoist, B. Pereira, F. Chiambaretta, F. Dutheil // PLoS One. -2016. - 11(12)","Cannon, W.B. The wisdom of the body / W.B. Cannon, Norton W.W. // New York: -1932","Graham, K.L. Genetic and Biochemical Biomarkers in Canine Glaucoma / K.L. Graham, C. McCowan, A.White// Vet Pathol. - 2016 Sep 28","Kaluza, G. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients /G. Kaluza, I. Strempel, H. Maurer // J Behav Med. -1996. -19(6). - P. 587-98","Kennard, J. Brief History of the term / J. Kennard, A. Brief Stress. - 2008. URL: http://www.healthcentral.com/anxiety/c/1950/30437/ history-term-stress/","Lescouflair, E. Experimental Physiologist / E. Lescouflair, W. B. Cannon // Harvard College. - 2003","Quick, J. C. Pioneer of stress research / J.C. Quick, C. D. Spielberger, Cannon W. B. // International Journal of Stress Management. - Volume 1. - Number 2, April, -1994. - P. 141-143","Severn, P. Which quality of life score is best for glaucoma patients and why? / P. Severn, S. Fraser, T. Finch, C. May // BMC Ophthalmol. - 2008. - V.8. - P. 2","Shily, B.G. Psychophysiological stress, elevated intraocular pressure, and acute closed-angle glaucoma / B.G.Shily // Am J Optom Physiol Opt. -1987. - 64(11). - P. 866-870","Simona, L. Low vision and rehabilitation for the elderly: the integration of services in the health system / L. Simona // Community eye health. - 2008. - Vol. 21 (66). - P.28-30","Авербах, М.И. Офтальмологические очерки / М.И. Авербах. - М., 1949. - С. 357","Алексеев, В.Н. Зависимость стабилизации зрительных функций от уровня внутриглазного давления у больных первичной открытоугольной глаукомой / В.Н. Алексеев, Т.Г. Зубкова, О.А. Малеванная // Сб. науч. тр. регион. конф. «Глаукома: теория и практика». - СПб., 2008. - С. 7-11","Басинский, С.Н. Психоэмоциональные нарушения у пациентов с глаукомой и возможности их фармакокоррекции в комплексном лечении заболевания / С.Н. Басинский, В.Н. Красногорская, А.С. Басинский, И.Н. Рогачев // Русский медицинский журнал. Клиническая офтальмольмология. - 2009. - № 4. - С.133","Бойко, Э.В. Качество жизни и психологический статус больных с глаукомой и катарактой / Э.В. Бойко, В.Н. Сысоев, А.А. Новик, О.В. Кузьмичева // Глаукома. - 2010. - № 1. - С. 21-25","Габдрахманова, А.Ф. Некоторые аспекты комплексного лечения открытоугольной глаукомы / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Медицинский вестник Башкортостана. - 2014. - Т. 9, № 2. - С. 42-45","Габдрахманова, А.Ф. Новые подходы к коррекции нарушений психологического статуса и качества жизни больных первичной открытоугольной глаукомой / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Вестник Кыргызско-Российского славянского университета. - 2013. - Т. 13, № 9. - С. 194-196","Габдрахманова, А.Ф. Первые результаты оценки качества жизни пациентов с глаукомой в Республике Башкортостан / А.Ф. Габдрахманова, С.А. Курбанов // Российский офтальмологический журнал. - 2013. - Т. 6, № 2. - С. 16-19","Гизатуллина, Е.А. Динамика зрительных функций при первичной открытоугольной глаукоме с нормализованным внутриглазным давлением у больных с различной стресс-резистентностью / Е.А.Гизатуллина, И.Г.Брындина, В.В.Жаров // Вестник Оренбургского государственного университета -2011. - № 14. - С.88-89","Егоров, Е.А. Национальное руководство по глаукоме для практикующих врачей / Е.А. Егоров, Ю.С. Астахов, В.П. Еричев. - М.: ГЭОТАР-Медиа, 2015. - 456 с","Егоров, Е.А. Национальное руководство по глаукоме / Е.А. Егоров. - М.: ГЕОТАР-Медиа, 2013. - 824 с","Изевлина, Н.Л. Психологические особенности больных с псевдоэксфолиативной глаукомой / Н.Л. Изевлина, Л.М. Габдрахманов М.В. Шевченко, Ф.С. Галеева // Ерошевские чтения - 2007. - Самара, 2007. - С. 93-95","Изевлина, Н.Л. Результаты психодиагностических исследований у больных первичной открытоугольной глаукомой / Н.Л. Изевлина, М.В. Шевченко, Т.Н. Лумпова // Материалы III Евроазиатской конф. по офтальмохирургии. - Екатеринбург, 2003.- С. 168-171","Казачкова, Л.Е. Личностные особенности больных первичной открытоугольной глаукомой / Л.Е. Казачкова, Е.В. Козина // Материалы научно-практ. конф. офтальмологов Сибири и Дальнего Востока. - Владивосток, 2000. - С. 14-16","Карвасарский, Б.Д. Психотерапия / Б.Д. Карвасарский. - СПб.: Питер, 2012. - 674 с","Козина, Е.В. Качество жизни больных первичной открытоугольной глаукомой / Е.В. Козина // Русский медицинский журнал. Клиническая офтальмология. -2003. - № 3. - С.137","Мягков, А.В. Влияние психоэмоционального стресса на внутриглазное давление и формирование офтальмогипертензии / А.В. Мягков // Казанский медицинский журнал. - 2002. - № 2.- С. 72-73","Соколов, В.А. Первичная открытоугольная глаукома: психосоматические черты болезни / В.А. Соколов, М.Н. Чернобавская // Глаукома: теории, тенденции, технологии: сб. науч. ст. - М., 2011. - С. 295-298","Depression, anxiety and disturbed sleep in glaucoma / A. Agorastos [et al.] // Journal of Neuropsychiatry and clinical neurosciences. - 2013. - Vol. 25. - P. 205-213","Aspinall, P.A. Quality of life in glaucoma and its relationship with visual function / P.A. Aspinall, Z.K. Johnson, A. Azuara-Blanco, A. Montarzino, R. Brice, A.Vickers // J. Glaucoma. - 2003. - 12(2). - P.139-50","Benoist, D. C. Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis. / C.D. Benoist, B. Pereira, F. Chiambaretta, F. Dutheil // PLoS One. -2016. - 11(12)","Cannon, W.B. The wisdom of the body / W.B. Cannon, Norton W.W. // New York: -1932","Graham, K.L. Genetic and Biochemical Biomarkers in Canine Glaucoma / K.L. Graham, C. McCowan, A.White// Vet Pathol. - 2016 Sep 28","Kaluza, G. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients /G. Kaluza, I. Strempel, H. Maurer // J Behav Med. -1996. -19(6). - P. 587-98","Kennard, J. Brief History of the term / J. Kennard, A. Brief Stress. - 2008. URL: http://www.healthcentral.com/anxiety/c/1950/30437/ history-term-stress/","Lescouflair, E. Experimental Physiologist / E. Lescouflair, W. B. Cannon // Harvard College. - 2003","Quick, J. C. Pioneer of stress research / J.C. Quick, C. D. Spielberger, Cannon W. B. // International Journal of Stress Management. - Volume 1. - Number 2, April, -1994. - P. 141-143","Severn, P. Which quality of life score is best for glaucoma patients and why? / P. Severn, S. Fraser, T. Finch, C. May // BMC Ophthalmol. - 2008. - V.8. - P. 2","Shily, B.G. Psychophysiological stress, elevated intraocular pressure, and acute closed-angle glaucoma / B.G.Shily // Am J Optom Physiol Opt. -1987. - 64(11). - P. 866-870","Simona, L. Low vision and rehabilitation for the elderly: the integration of services in the health system / L. Simona // Community eye health. - 2008. - Vol. 21 (66). - P.28-30"],"dc.citation.ru":["Авербах, М.И. Офтальмологические очерки / М.И. Авербах. - М., 1949. - С. 357","Алексеев, В.Н. Зависимость стабилизации зрительных функций от уровня внутриглазного давления у больных первичной открытоугольной глаукомой / В.Н. Алексеев, Т.Г. Зубкова, О.А. Малеванная // Сб. науч. тр. регион. конф. «Глаукома: теория и практика». - СПб., 2008. - С. 7-11","Басинский, С.Н. Психоэмоциональные нарушения у пациентов с глаукомой и возможности их фармакокоррекции в комплексном лечении заболевания / С.Н. Басинский, В.Н. Красногорская, А.С. Басинский, И.Н. Рогачев // Русский медицинский журнал. Клиническая офтальмольмология. - 2009. - № 4. - С.133","Бойко, Э.В. Качество жизни и психологический статус больных с глаукомой и катарактой / Э.В. Бойко, В.Н. Сысоев, А.А. Новик, О.В. Кузьмичева // Глаукома. - 2010. - № 1. - С. 21-25","Габдрахманова, А.Ф. Некоторые аспекты комплексного лечения открытоугольной глаукомы / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Медицинский вестник Башкортостана. - 2014. - Т. 9, № 2. - С. 42-45","Габдрахманова, А.Ф. Новые подходы к коррекции нарушений психологического статуса и качества жизни больных первичной открытоугольной глаукомой / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Вестник Кыргызско-Российского славянского университета. - 2013. - Т. 13, № 9. - С. 194-196","Габдрахманова, А.Ф. Первые результаты оценки качества жизни пациентов с глаукомой в Республике Башкортостан / А.Ф. Габдрахманова, С.А. Курбанов // Российский офтальмологический журнал. - 2013. - Т. 6, № 2. - С. 16-19","Гизатуллина, Е.А. Динамика зрительных функций при первичной открытоугольной глаукоме с нормализованным внутриглазным давлением у больных с различной стресс-резистентностью / Е.А.Гизатуллина, И.Г.Брындина, В.В.Жаров // Вестник Оренбургского государственного университета -2011. - № 14. - С.88-89","Егоров, Е.А. Национальное руководство по глаукоме для практикующих врачей / Е.А. Егоров, Ю.С. Астахов, В.П. Еричев. - М.: ГЭОТАР-Медиа, 2015. - 456 с","Егоров, Е.А. Национальное руководство по глаукоме / Е.А. Егоров. - М.: ГЕОТАР-Медиа, 2013. - 824 с","Изевлина, Н.Л. Психологические особенности больных с псевдоэксфолиативной глаукомой / Н.Л. Изевлина, Л.М. Габдрахманов М.В. Шевченко, Ф.С. Галеева // Ерошевские чтения - 2007. - Самара, 2007. - С. 93-95","Изевлина, Н.Л. Результаты психодиагностических исследований у больных первичной открытоугольной глаукомой / Н.Л. Изевлина, М.В. Шевченко, Т.Н. Лумпова // Материалы III Евроазиатской конф. по офтальмохирургии. - Екатеринбург, 2003.- С. 168-171","Казачкова, Л.Е. Личностные особенности больных первичной открытоугольной глаукомой / Л.Е. Казачкова, Е.В. Козина // Материалы научно-практ. конф. офтальмологов Сибири и Дальнего Востока. - Владивосток, 2000. - С. 14-16","Карвасарский, Б.Д. Психотерапия / Б.Д. Карвасарский. - СПб.: Питер, 2012. - 674 с","Козина, Е.В. Качество жизни больных первичной открытоугольной глаукомой / Е.В. Козина // Русский медицинский журнал. Клиническая офтальмология. -2003. - № 3. - С.137","Мягков, А.В. Влияние психоэмоционального стресса на внутриглазное давление и формирование офтальмогипертензии / А.В. Мягков // Казанский медицинский журнал. - 2002. - № 2.- С. 72-73","Соколов, В.А. Первичная открытоугольная глаукома: психосоматические черты болезни / В.А. Соколов, М.Н. Чернобавская // Глаукома: теории, тенденции, технологии: сб. науч. ст. - М., 2011. - С. 295-298","Depression, anxiety and disturbed sleep in glaucoma / A. Agorastos [et al.] // Journal of Neuropsychiatry and clinical neurosciences. - 2013. - Vol. 25. - P. 205-213","Aspinall, P.A. Quality of life in glaucoma and its relationship with visual function / P.A. Aspinall, Z.K. Johnson, A. Azuara-Blanco, A. Montarzino, R. Brice, A.Vickers // J. Glaucoma. - 2003. - 12(2). - P.139-50","Benoist, D. C. Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis. / C.D. Benoist, B. Pereira, F. Chiambaretta, F. Dutheil // PLoS One. -2016. - 11(12)","Cannon, W.B. The wisdom of the body / W.B. Cannon, Norton W.W. // New York: -1932","Graham, K.L. Genetic and Biochemical Biomarkers in Canine Glaucoma / K.L. Graham, C. McCowan, A.White// Vet Pathol. - 2016 Sep 28","Kaluza, G. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients /G. Kaluza, I. Strempel, H. Maurer // J Behav Med. -1996. -19(6). - P. 587-98","Kennard, J. Brief History of the term / J. Kennard, A. Brief Stress. - 2008. URL: http://www.healthcentral.com/anxiety/c/1950/30437/ history-term-stress/","Lescouflair, E. Experimental Physiologist / E. Lescouflair, W. B. Cannon // Harvard College. - 2003","Quick, J. C. Pioneer of stress research / J.C. Quick, C. D. Spielberger, Cannon W. B. // International Journal of Stress Management. - Volume 1. - Number 2, April, -1994. - P. 141-143","Severn, P. Which quality of life score is best for glaucoma patients and why? / P. Severn, S. Fraser, T. Finch, C. May // BMC Ophthalmol. - 2008. - V.8. - P. 2","Shily, B.G. Psychophysiological stress, elevated intraocular pressure, and acute closed-angle glaucoma / B.G.Shily // Am J Optom Physiol Opt. -1987. - 64(11). - P. 866-870","Simona, L. Low vision and rehabilitation for the elderly: the integration of services in the health system / L. Simona // Community eye health. - 2008. - Vol. 21 (66). - P.28-30"],"dc.citation.en":["Авербах, М.И. Офтальмологические очерки / М.И. Авербах. - М., 1949. - С. 357","Алексеев, В.Н. Зависимость стабилизации зрительных функций от уровня внутриглазного давления у больных первичной открытоугольной глаукомой / В.Н. Алексеев, Т.Г. Зубкова, О.А. Малеванная // Сб. науч. тр. регион. конф. «Глаукома: теория и практика». - СПб., 2008. - С. 7-11","Басинский, С.Н. Психоэмоциональные нарушения у пациентов с глаукомой и возможности их фармакокоррекции в комплексном лечении заболевания / С.Н. Басинский, В.Н. Красногорская, А.С. Басинский, И.Н. Рогачев // Русский медицинский журнал. Клиническая офтальмольмология. - 2009. - № 4. - С.133","Бойко, Э.В. Качество жизни и психологический статус больных с глаукомой и катарактой / Э.В. Бойко, В.Н. Сысоев, А.А. Новик, О.В. Кузьмичева // Глаукома. - 2010. - № 1. - С. 21-25","Габдрахманова, А.Ф. Некоторые аспекты комплексного лечения открытоугольной глаукомы / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Медицинский вестник Башкортостана. - 2014. - Т. 9, № 2. - С. 42-45","Габдрахманова, А.Ф. Новые подходы к коррекции нарушений психологического статуса и качества жизни больных первичной открытоугольной глаукомой / А.Ф. Габдрахманова, Е.Р. Кунафина, С.А. Курбанов // Вестник Кыргызско-Российского славянского университета. - 2013. - Т. 13, № 9. - С. 194-196","Габдрахманова, А.Ф. Первые результаты оценки качества жизни пациентов с глаукомой в Республике Башкортостан / А.Ф. Габдрахманова, С.А. Курбанов // Российский офтальмологический журнал. - 2013. - Т. 6, № 2. - С. 16-19","Гизатуллина, Е.А. Динамика зрительных функций при первичной открытоугольной глаукоме с нормализованным внутриглазным давлением у больных с различной стресс-резистентностью / Е.А.Гизатуллина, И.Г.Брындина, В.В.Жаров // Вестник Оренбургского государственного университета -2011. - № 14. - С.88-89","Егоров, Е.А. Национальное руководство по глаукоме для практикующих врачей / Е.А. Егоров, Ю.С. Астахов, В.П. Еричев. - М.: ГЭОТАР-Медиа, 2015. - 456 с","Егоров, Е.А. Национальное руководство по глаукоме / Е.А. Егоров. - М.: ГЕОТАР-Медиа, 2013. - 824 с","Изевлина, Н.Л. Психологические особенности больных с псевдоэксфолиативной глаукомой / Н.Л. Изевлина, Л.М. Габдрахманов М.В. Шевченко, Ф.С. Галеева // Ерошевские чтения - 2007. - Самара, 2007. - С. 93-95","Изевлина, Н.Л. Результаты психодиагностических исследований у больных первичной открытоугольной глаукомой / Н.Л. Изевлина, М.В. Шевченко, Т.Н. Лумпова // Материалы III Евроазиатской конф. по офтальмохирургии. - Екатеринбург, 2003.- С. 168-171","Казачкова, Л.Е. Личностные особенности больных первичной открытоугольной глаукомой / Л.Е. Казачкова, Е.В. Козина // Материалы научно-практ. конф. офтальмологов Сибири и Дальнего Востока. - Владивосток, 2000. - С. 14-16","Карвасарский, Б.Д. Психотерапия / Б.Д. Карвасарский. - СПб.: Питер, 2012. - 674 с","Козина, Е.В. Качество жизни больных первичной открытоугольной глаукомой / Е.В. Козина // Русский медицинский журнал. Клиническая офтальмология. -2003. - № 3. - С.137","Мягков, А.В. Влияние психоэмоционального стресса на внутриглазное давление и формирование офтальмогипертензии / А.В. Мягков // Казанский медицинский журнал. - 2002. - № 2.- С. 72-73","Соколов, В.А. Первичная открытоугольная глаукома: психосоматические черты болезни / В.А. Соколов, М.Н. Чернобавская // Глаукома: теории, тенденции, технологии: сб. науч. ст. - М., 2011. - С. 295-298","Depression, anxiety and disturbed sleep in glaucoma / A. Agorastos [et al.] // Journal of Neuropsychiatry and clinical neurosciences. - 2013. - Vol. 25. - P. 205-213","Aspinall, P.A. Quality of life in glaucoma and its relationship with visual function / P.A. Aspinall, Z.K. Johnson, A. Azuara-Blanco, A. Montarzino, R. Brice, A.Vickers // J. Glaucoma. - 2003. - 12(2). - P.139-50","Benoist, D. C. Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis. / C.D. Benoist, B. Pereira, F. Chiambaretta, F. Dutheil // PLoS One. -2016. - 11(12)","Cannon, W.B. The wisdom of the body / W.B. Cannon, Norton W.W. // New York: -1932","Graham, K.L. Genetic and Biochemical Biomarkers in Canine Glaucoma / K.L. Graham, C. McCowan, A.White// Vet Pathol. - 2016 Sep 28","Kaluza, G. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients /G. Kaluza, I. Strempel, H. Maurer // J Behav Med. -1996. -19(6). - P. 587-98","Kennard, J. Brief History of the term / J. Kennard, A. Brief Stress. - 2008. URL: http://www.healthcentral.com/anxiety/c/1950/30437/ history-term-stress/","Lescouflair, E. Experimental Physiologist / E. Lescouflair, W. B. Cannon // Harvard College. - 2003","Quick, J. C. Pioneer of stress research / J.C. Quick, C. D. Spielberger, Cannon W. B. // International Journal of Stress Management. - Volume 1. - Number 2, April, -1994. - P. 141-143","Severn, P. Which quality of life score is best for glaucoma patients and why? / P. Severn, S. Fraser, T. Finch, C. May // BMC Ophthalmol. - 2008. - V.8. - P. 2","Shily, B.G. Psychophysiological stress, elevated intraocular pressure, and acute closed-angle glaucoma / B.G.Shily // Am J Optom Physiol Opt. -1987. - 64(11). - P. 866-870","Simona, L. Low vision and rehabilitation for the elderly: the integration of services in the health system / L. Simona // Community eye health. - 2008. - Vol. 21 (66). - P.28-30"],"dc.author.full":["С. А. Курбанов | ГБУЗ РБ «Городская клиническая больница №10»","S. A. Kurbanov |","А. Ф. Габдрахманова | ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России","A. F. Gabdrakhmanova |"],"dc.author.full.ru":["С. А. Курбанов | ГБУЗ РБ «Городская клиническая больница №10»","А. Ф. Габдрахманова | ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России"],"dc.author.full.en":["S. A. Kurbanov |","A. F. Gabdrakhmanova |"],"dc.section":["ГЛАУКОМА"],"dc.section.ru":["ГЛАУКОМА"],"dc.abstract":["Glaucoma is a chronic pathology, that is why its treatment is a long and permanent process aimed at preserving visual function. During treatment, a patient should take one, two or several antihypertensive local medications, which causes a number of disadvantages associated with the treatment regimen, side effects of drugs that affect the quality of life and psycho-emotional state of patients, as well as the development of borderline mental disorders and stress. Any non-specific reactions can be accompanied by anxiety or fear. During repeated impacts of psychogenic factors the response acquires specificity as internal tensions, depression and others. This has a negative effect both on the pathologic process and its treatment. Many authors have described the influence of emotional stress, certain somatic abnormalities on the level of IOP and glaucoma development.","Глаукома - хроническая патология, в связи с этим ее лечение - длительный и постоянный процесс, направленный на сохранение зрительных функций. В ходе лечения пациент должен принимать один или несколько гипотензивных местных препаратов, что вызывает ряд неудобств, связанных с режимом лечения, побочными эффектами препаратов, влияющих на качество жизни и психоэмоциональное состояние больных, а также на развитие пограничных психических расстройств и стресса. Любая неспецифическая реакция может сопровождаться тревогой или страхом. При повторных воздействиях психогенных факторов ответная реакция приобретает специфичность в виде внутренней напряженности, депрессивности и пр. Это оказывает негативное влияние как на течение патологического процесса, так и на его лечение. Многими авторами описано влияние психоэмоционального стресса и некоторых соматических патологий на уровень внутриглазного давления и развитие глаукомы."],"dc.abstract.en":["Glaucoma is a chronic pathology, that is why its treatment is a long and permanent process aimed at preserving visual function. During treatment, a patient should take one, two or several antihypertensive local medications, which causes a number of disadvantages associated with the treatment regimen, side effects of drugs that affect the quality of life and psycho-emotional state of patients, as well as the development of borderline mental disorders and stress. Any non-specific reactions can be accompanied by anxiety or fear. During repeated impacts of psychogenic factors the response acquires specificity as internal tensions, depression and others. This has a negative effect both on the pathologic process and its treatment. Many authors have described the influence of emotional stress, certain somatic abnormalities on the level of IOP and glaucoma development."],"dc.abstract.ru":["Глаукома - хроническая патология, в связи с этим ее лечение - длительный и постоянный процесс, направленный на сохранение зрительных функций. В ходе лечения пациент должен принимать один или несколько гипотензивных местных препаратов, что вызывает ряд неудобств, связанных с режимом лечения, побочными эффектами препаратов, влияющих на качество жизни и психоэмоциональное состояние больных, а также на развитие пограничных психических расстройств и стресса. Любая неспецифическая реакция может сопровождаться тревогой или страхом. При повторных воздействиях психогенных факторов ответная реакция приобретает специфичность в виде внутренней напряженности, депрессивности и пр. Это оказывает негативное влияние как на течение патологического процесса, так и на его лечение. Многими авторами описано влияние психоэмоционального стресса и некоторых соматических патологий на уровень внутриглазного давления и развитие глаукомы."],"dc.pages":["91-93"],"author":["С. А. Курбанов","S. A. Kurbanov","А. Ф. Габдрахманова","A. F. Gabdrakhmanova"],"author_keyword":["С. А. Курбанов","S. A. Kurbanov","А. Ф. Габдрахманова","A. F. Gabdrakhmanova"],"author_ac":["с. а. курбанов\n|||\nС. А. Курбанов","s. a. kurbanov\n|||\nS. A. Kurbanov","а. ф. габдрахманова\n|||\nА. Ф. Габдрахманова","a. f. gabdrakhmanova\n|||\nA. F. Gabdrakhmanova"],"author_filter":["с. а. курбанов\n|||\nС. А. Курбанов","s. a. kurbanov\n|||\nS. A. Kurbanov","а. ф. габдрахманова\n|||\nА. Ф. Габдрахманова","a. f. gabdrakhmanova\n|||\nA. F. Gabdrakhmanova"],"dc.author.name":["С. А. Курбанов","S. A. Kurbanov","А. Ф. Габдрахманова","A. F. Gabdrakhmanova"],"dc.author.name.ru":["С. А. Курбанов","А. Ф. Габдрахманова"],"dc.author.name.en":["S. A. Kurbanov","A. F. Gabdrakhmanova"],"dc.author.affiliation":["ГБУЗ РБ «Городская клиническая больница №10»","ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России"],"dc.author.affiliation.ru":["ГБУЗ РБ «Городская клиническая больница №10»","ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России"],"dc.issue.number":["2"],"dc.issue.volume":["12"],"dc.origin":["https://medvestb.elpub.ru/jour/article/view/56"],"dc.authors":["{\"authors\": [{\"ru\": {\"affiliation\": \"\\u0413\\u0411\\u0423\\u0417 \\u0420\\u0411 \\u00ab\\u0413\\u043e\\u0440\\u043e\\u0434\\u0441\\u043a\\u0430\\u044f \\u043a\\u043b\\u0438\\u043d\\u0438\\u0447\\u0435\\u0441\\u043a\\u0430\\u044f \\u0431\\u043e\\u043b\\u044c\\u043d\\u0438\\u0446\\u0430 \\u211610\\u00bb\", \"full_name\": \"\\u0421. \\u0410. \\u041a\\u0443\\u0440\\u0431\\u0430\\u043d\\u043e\\u0432\"}, \"en\": {\"affiliation\": \"\", \"full_name\": \"S. A. Kurbanov\"}}, {\"ru\": {\"affiliation\": \"\\u0424\\u0413\\u0411\\u041e\\u0423 \\u0412\\u041e \\u00ab\\u0411\\u0430\\u0448\\u043a\\u0438\\u0440\\u0441\\u043a\\u0438\\u0439 \\u0433\\u043e\\u0441\\u0443\\u0434\\u0430\\u0440\\u0441\\u0442\\u0432\\u0435\\u043d\\u043d\\u044b\\u0439 \\u043c\\u0435\\u0434\\u0438\\u0446\\u0438\\u043d\\u0441\\u043a\\u0438\\u0439 \\u0443\\u043d\\u0438\\u0432\\u0435\\u0440\\u0441\\u0438\\u0442\\u0435\\u0442\\u00bb \\u041c\\u0438\\u043d\\u0437\\u0434\\u0440\\u0430\\u0432\\u0430 \\u0420\\u043e\\u0441\\u0441\\u0438\\u0438\", \"full_name\": \"\\u0410. \\u0424. \\u0413\\u0430\\u0431\\u0434\\u0440\\u0430\\u0445\\u043c\\u0430\\u043d\\u043e\\u0432\\u0430\"}, \"en\": {\"affiliation\": \"\", \"full_name\": \"A. F. Gabdrakhmanova\"}}]}"],"publication_grp":["123456789/5453"],"bi_4_dis_filter":["глаукома\n|||\nглаукома","психоэмоциональное состояние\n|||\nпсихоэмоциональное состояние","intraocular pressure\n|||\nintraocular pressure","внутриглазное давление\n|||\nвнутриглазное давление","glaucoma\n|||\nglaucoma","psycho-emotional state\n|||\npsycho-emotional state","markers\n|||\nmarkers","stress\n|||\nstress","стресс\n|||\nстресс","маркеры\n|||\nмаркеры"],"bi_4_dis_partial":["stress","глаукома","psycho-emotional state","intraocular pressure","glaucoma","внутриглазное давление","стресс","маркеры","markers","психоэмоциональное состояние"],"bi_4_dis_value_filter":["stress","глаукома","psycho-emotional state","intraocular pressure","glaucoma","внутриглазное давление","стресс","маркеры","markers","психоэмоциональное состояние"],"bi_sort_1_sort":"stress factor in glaucoma development","bi_sort_3_sort":"2021-01-14T11:51:30Z","read":["g0"],"_version_":1697558606775320576},{"SolrIndexer.lastIndexed":"2023-10-18T08:57:15.719Z","search.uniqueid":"2-7042","search.resourcetype":2,"search.resourceid":7042,"handle":"123456789/7920","location":["m229","l684"],"location.comm":["229"],"location.coll":["684"],"withdrawn":"false","discoverable":"true","dc.abstract":["Cognitive disorders (CD) are observed in more than half of patients with amyotrophic lateral sclerosis (ALS), but rarely reach the degree of dementia. Currently, a classification of ALS has been proposed depending on the presence of cognitive and/or behavioral disorders. CD in ALS can be represented by speech fluency disorders, various aphasic disorders, disorders of regulatory functions, social cognitive functions, and verbal memory. The most diagnostically sensitive are special scales, such as the Edinburgh Cognitive and Behavioral Impairment Screening Scale for ALS. CD in ALS have a negative impact on the outcome of the disease and the quality of life of patients and their families. This issue requires further study. © 2023 Ima-Press Publishing House. All rights reserved."],"dc.abstract.en":["Cognitive disorders (CD) are observed in more than half of patients with amyotrophic lateral sclerosis (ALS), but rarely reach the degree of dementia. Currently, a classification of ALS has been proposed depending on the presence of cognitive and/or behavioral disorders. CD in ALS can be represented by speech fluency disorders, various aphasic disorders, disorders of regulatory functions, social cognitive functions, and verbal memory. The most diagnostically sensitive are special scales, such as the Edinburgh Cognitive and Behavioral Impairment Screening Scale for ALS. CD in ALS have a negative impact on the outcome of the disease and the quality of life of patients and their families. This issue requires further study. © 2023 Ima-Press Publishing House. All rights reserved."],"author":["Кутлубаев, М.А.","Арепринцева, Д.К.","Первушина, Е.В.","Брылев, Л.В.","Kutlubaev, M.A.","Areprintceva, D.K.","Pervushina, E.V.","Brylev, L.V."],"author_keyword":["Кутлубаев, М.А.","Арепринцева, Д.К.","Первушина, Е.В.","Брылев, Л.В.","Kutlubaev, M.A.","Areprintceva, D.K.","Pervushina, E.V.","Brylev, L.V."],"author_ac":["кутлубаев, м.а.\n|||\nКутлубаев, М.А.","арепринцева, д.к.\n|||\nАрепринцева, Д.К.","первушина, е.в.\n|||\nПервушина, Е.В.","брылев, л.в.\n|||\nБрылев, Л.В.","kutlubaev, m.a.\n|||\nKutlubaev, M.A.","areprintceva, d.k.\n|||\nAreprintceva, D.K.","pervushina, e.v.\n|||\nPervushina, E.V.","brylev, l.v.\n|||\nBrylev, L.V."],"author_filter":["кутлубаев, м.а.\n|||\nКутлубаев, М.А.","арепринцева, д.к.\n|||\nАрепринцева, Д.К.","первушина, е.в.\n|||\nПервушина, Е.В.","брылев, л.в.\n|||\nБрылев, Л.В.","kutlubaev, m.a.\n|||\nKutlubaev, M.A.","areprintceva, d.k.\n|||\nAreprintceva, D.K.","pervushina, e.v.\n|||\nPervushina, E.V.","brylev, l.v.\n|||\nBrylev, L.V."],"dc.contributor.author_hl":["Кутлубаев, М.А.","Арепринцева, Д.К.","Первушина, Е.В.","Брылев, Л.В.","Kutlubaev, M.A.","Areprintceva, D.K.","Pervushina, E.V.","Brylev, L.V."],"dc.contributor.author_mlt":["Кутлубаев, М.А.","Арепринцева, Д.К.","Первушина, Е.В.","Брылев, Л.В.","Kutlubaev, M.A.","Areprintceva, D.K.","Pervushina, E.V.","Brylev, L.V."],"dc.contributor.author":["Кутлубаев, М.А.","Арепринцева, Д.К.","Первушина, Е.В.","Брылев, Л.В.","Kutlubaev, M.A.","Areprintceva, D.K.","Pervushina, E.V.","Brylev, L.V."],"dc.contributor.author_stored":["Кутлубаев, М.А.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Арепринцева, Д.К.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Первушина, Е.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Брылев, Л.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Kutlubaev, M.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Areprintceva, D.K.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Pervushina, E.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Brylev, L.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.ru_RU":["Кутлубаев, М.А.","Арепринцева, Д.К.","Первушина, Е.В.","Брылев, Л.В."],"dc.contributor.author.en":["Kutlubaev, M.A.","Areprintceva, D.K.","Pervushina, E.V.","Brylev, L.V."],"dc.date.accessioned_dt":"2023-10-18T08:55:56Z","dc.date.accessioned":["2023-10-18T08:55:56Z"],"dc.date.available":["2023-10-18T08:55:56Z"],"dateIssued":["2023-01-01"],"dateIssued_keyword":["2023-01-01","2023"],"dateIssued_ac":["2023-01-01\n|||\n2023-01-01","2023"],"dateIssued.year":[2023],"dateIssued.year_sort":"2023","dc.date.issued_dt":"2023-01-01T00:00:00Z","dc.date.issued":["2023-01-01"],"dc.date.issued_stored":["2023-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.description.abstract_hl":["Когнитивные нарушения (КН) наблюдаются более чем у половины пациентов с боковым амитрофическим склерозом (БАС), но редко достигают степени деменции. В настоящее время предложена классификация БАС в зависимости от наличия когнитивных\nи/или поведенческих нарушений. КН при БАС могут быть представлены нарушениями беглости речи, различными афатическими\nрасстройствами, нарушениями регуляторных функций, социальных когнитивных функций и вербальной памяти. Для их диагностики наиболее чувствительны специальные шкалы, такие как Эдинбургская шкала скрининга когнитивных и поведенческих нарушений при БАС. КН при БАС оказывают негативное влияние на исход заболевания и качество жизни пациентов и их семей. Данная\nпроблема требует дальнейшего изучения."],"dc.description.abstract":["Когнитивные нарушения (КН) наблюдаются более чем у половины пациентов с боковым амитрофическим склерозом (БАС), но редко достигают степени деменции. В настоящее время предложена классификация БАС в зависимости от наличия когнитивных\nи/или поведенческих нарушений. КН при БАС могут быть представлены нарушениями беглости речи, различными афатическими\nрасстройствами, нарушениями регуляторных функций, социальных когнитивных функций и вербальной памяти. Для их диагностики наиболее чувствительны специальные шкалы, такие как Эдинбургская шкала скрининга когнитивных и поведенческих нарушений при БАС. КН при БАС оказывают негативное влияние на исход заболевания и качество жизни пациентов и их семей. Данная\nпроблема требует дальнейшего изучения."],"dc.description.abstract.ru_RU":["Когнитивные нарушения (КН) наблюдаются более чем у половины пациентов с боковым амитрофическим склерозом (БАС), но редко достигают степени деменции. В настоящее время предложена классификация БАС в зависимости от наличия когнитивных\nи/или поведенческих нарушений. КН при БАС могут быть представлены нарушениями беглости речи, различными афатическими\nрасстройствами, нарушениями регуляторных функций, социальных когнитивных функций и вербальной памяти. Для их диагностики наиболее чувствительны специальные шкалы, такие как Эдинбургская шкала скрининга когнитивных и поведенческих нарушений при БАС. КН при БАС оказывают негативное влияние на исход заболевания и качество жизни пациентов и их семей. Данная\nпроблема требует дальнейшего изучения."],"dc.doi":["10.14412/2074-2711-2023-2-68-74"],"dc.doi.en":["10.14412/2074-2711-2023-2-68-74"],"dc.identifier.issn":["2074-2711"],"dc.identifier.uri":["http://hdl.handle.net/123456789/7920"],"dc.publisher":["Ima-Press Publishing House"],"dc.publisher.en":["Ima-Press Publishing House"],"dc.relation.ispartofseries":["Nevrologiya, Neiropsikhiatriya, Psikhosomatika;v.15 № 2"],"dc.relation.ispartofseries.en":["Nevrologiya, Neiropsikhiatriya, Psikhosomatika;v.15 № 2"],"subject":["боковой амиотрофический склероз","когнитивные нарушения","деменция","Scopus","amyotrophic lateral sclerosis","cognitive impairment","dementia"],"subject_keyword":["боковой амиотрофический склероз","боковой амиотрофический склероз","когнитивные нарушения","когнитивные нарушения","деменция","деменция","Scopus","Scopus","amyotrophic lateral sclerosis","amyotrophic lateral sclerosis","cognitive impairment","cognitive impairment","dementia","dementia"],"subject_ac":["боковой амиотрофический склероз\n|||\nбоковой амиотрофический склероз","когнитивные нарушения\n|||\nкогнитивные нарушения","деменция\n|||\nдеменция","scopus\n|||\nScopus","amyotrophic lateral sclerosis\n|||\namyotrophic lateral sclerosis","cognitive impairment\n|||\ncognitive impairment","dementia\n|||\ndementia"],"subject_tax_0_filter":["боковой амиотрофический склероз\n|||\nбоковой амиотрофический склероз","когнитивные нарушения\n|||\nкогнитивные нарушения","деменция\n|||\nдеменция","scopus\n|||\nScopus","amyotrophic lateral sclerosis\n|||\namyotrophic lateral sclerosis","cognitive impairment\n|||\ncognitive impairment","dementia\n|||\ndementia"],"subject_filter":["боковой амиотрофический склероз\n|||\nбоковой амиотрофический склероз","когнитивные нарушения\n|||\nкогнитивные нарушения","деменция\n|||\nдеменция","scopus\n|||\nScopus","amyotrophic lateral sclerosis\n|||\namyotrophic lateral sclerosis","cognitive impairment\n|||\ncognitive impairment","dementia\n|||\ndementia"],"dc.subject_mlt":["боковой амиотрофический склероз","когнитивные нарушения","деменция","Scopus","amyotrophic lateral sclerosis","cognitive impairment","dementia"],"dc.subject":["боковой амиотрофический склероз","когнитивные нарушения","деменция","Scopus","amyotrophic lateral sclerosis","cognitive impairment","dementia"],"dc.subject.ru_RU":["боковой амиотрофический склероз","когнитивные нарушения","деменция"],"dc.subject.en":["Scopus","amyotrophic lateral sclerosis","cognitive impairment","dementia"],"title":["Cognitive disorders in amyotrophic lateral sclerosis","Когнитивные нарушения при боковом амиотрофическом склерозе"],"title_keyword":["Cognitive disorders in amyotrophic lateral sclerosis","Когнитивные нарушения при боковом амиотрофическом склерозе"],"title_ac":["cognitive disorders in amyotrophic lateral sclerosis\n|||\nCognitive disorders in amyotrophic lateral sclerosis","когнитивные нарушения при боковом амиотрофическом склерозе\n|||\nКогнитивные нарушения при боковом амиотрофическом склерозе"],"dc.title_sort":"Cognitive disorders in amyotrophic lateral sclerosis","dc.title_hl":["Cognitive disorders in amyotrophic lateral sclerosis","Когнитивные нарушения при боковом амиотрофическом склерозе"],"dc.title_mlt":["Cognitive disorders in amyotrophic lateral sclerosis","Когнитивные нарушения при боковом амиотрофическом склерозе"],"dc.title":["Cognitive disorders in amyotrophic lateral sclerosis","Когнитивные нарушения при боковом амиотрофическом склерозе"],"dc.title_stored":["Cognitive disorders in amyotrophic lateral sclerosis\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Когнитивные нарушения при боковом амиотрофическом склерозе\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU"],"dc.title.en":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.title.ru_RU":["Когнитивные нарушения при боковом амиотрофическом склерозе"],"dc.title.alternative":["Cognitive disorders in amyotrophic lateral sclerosis","Когнитивные нарушения при боковом амиотрофическом склерозе"],"dc.title.alternative.en":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.title.alternative.ru_RU":["Когнитивные нарушения при боковом амиотрофическом склерозе"],"dc.type":["Article"],"dc.type.ru_RU":["Article"],"publication_grp":["123456789/7920"],"bi_2_dis_filter":["кутлубаев, м.а.\n|||\nКутлубаев, М.А.","areprintceva, d.k.\n|||\nAreprintceva, D.K.","брылев, л.в.\n|||\nБрылев, Л.В.","арепринцева, д.к.\n|||\nАрепринцева, Д.К.","kutlubaev, m.a.\n|||\nKutlubaev, M.A.","brylev, l.v.\n|||\nBrylev, L.V.","первушина, е.в.\n|||\nПервушина, Е.В.","pervushina, e.v.\n|||\nPervushina, E.V."],"bi_2_dis_partial":["Areprintceva, D.K.","Кутлубаев, М.А.","Brylev, L.V.","Pervushina, E.V.","Первушина, Е.В.","Арепринцева, Д.К.","Kutlubaev, M.A.","Брылев, Л.В."],"bi_2_dis_value_filter":["Areprintceva, D.K.","Кутлубаев, М.А.","Brylev, L.V.","Pervushina, E.V.","Первушина, Е.В.","Арепринцева, Д.К.","Kutlubaev, M.A.","Брылев, Л.В."],"bi_4_dis_filter":["cognitive impairment\n|||\ncognitive impairment","когнитивные нарушения\n|||\nкогнитивные нарушения","dementia\n|||\ndementia","scopus\n|||\nScopus","деменция\n|||\nдеменция","amyotrophic lateral sclerosis\n|||\namyotrophic lateral sclerosis","боковой амиотрофический склероз\n|||\nбоковой амиотрофический склероз"],"bi_4_dis_partial":["боковой амиотрофический склероз","Scopus","деменция","dementia","cognitive impairment","когнитивные нарушения","amyotrophic lateral sclerosis"],"bi_4_dis_value_filter":["боковой амиотрофический склероз","Scopus","деменция","dementia","cognitive impairment","когнитивные нарушения","amyotrophic lateral sclerosis"],"bi_sort_1_sort":"cognitive disorders in amyotrophic lateral sclerosis","bi_sort_2_sort":"2023","bi_sort_3_sort":"2023-10-18T08:55:56Z","read":["g0"],"_version_":1780082997438971904},{"SolrIndexer.lastIndexed":"2022-10-31T07:49:37.497Z","search.uniqueid":"2-6206","search.resourcetype":2,"search.resourceid":6206,"handle":"123456789/7111","location":["m195","l691"],"location.comm":["195"],"location.coll":["691"],"withdrawn":"false","discoverable":"true","dc.abstract":["Purpose: to identify the features of hemodynamic disorders in women with atrophic form of chronic endometritis (CE).\nMaterial and methods. 86 patients took part, who were divided into two groups: group 1 – 44 patients with CE and hemodynamic disorders in the endometrium, group 2 – 42 patients with CE without impaired microcirculation in the endometrium. All patients underwent an ultrasound examination with Doppler scanning on the 7th (+1) day after ovulation and endometrial biopsy with\nfurther histological and immunohistochemical studies: the expression of VEGF, TGF-β, CD 138 markers was determined.\nResults and discussion. Thus, in patients with chronic atrophic endometritis with impaired microcirculation, sexually transmitted diseases and Asherman's syndrome were more often detected, cycle disorders such as algomenorrhea and hypomenorrhea, and\nintrauterine intrauterine interventions in anamnesis are typical.\nConclusions. According to immunohistochemical studies in patients with hemodynamic disorders, the expression of VEGF is\nstatistically reduced, the expression of TGF-β is increased."],"dc.abstract.en":["Purpose: to identify the features of hemodynamic disorders in women with atrophic form of chronic endometritis (CE).\nMaterial and methods. 86 patients took part, who were divided into two groups: group 1 – 44 patients with CE and hemodynamic disorders in the endometrium, group 2 – 42 patients with CE without impaired microcirculation in the endometrium. All patients underwent an ultrasound examination with Doppler scanning on the 7th (+1) day after ovulation and endometrial biopsy with\nfurther histological and immunohistochemical studies: the expression of VEGF, TGF-β, CD 138 markers was determined.\nResults and discussion. Thus, in patients with chronic atrophic endometritis with impaired microcirculation, sexually transmitted diseases and Asherman's syndrome were more often detected, cycle disorders such as algomenorrhea and hypomenorrhea, and\nintrauterine intrauterine interventions in anamnesis are typical.\nConclusions. According to immunohistochemical studies in patients with hemodynamic disorders, the expression of VEGF is\nstatistically reduced, the expression of TGF-β is increased."],"author":["Газизова, Г.Х.","Масленников, А.В.","Ящук, А.Г.","Даутова, Л.А.","Ахметова, Э.В.","Gazizova, G.Kh.","Maslennikov, A.V.","Yashchuk, A.G.","Dautova, L.A.","Akhmetova, E.V."],"author_keyword":["Газизова, Г.Х.","Масленников, А.В.","Ящук, А.Г.","Даутова, Л.А.","Ахметова, Э.В.","Gazizova, G.Kh.","Maslennikov, A.V.","Yashchuk, A.G.","Dautova, L.A.","Akhmetova, E.V."],"author_ac":["газизова, г.х.\n|||\nГазизова, Г.Х.","масленников, а.в.\n|||\nМасленников, А.В.","ящук, а.г.\n|||\nЯщук, А.Г.","даутова, л.а.\n|||\nДаутова, Л.А.","ахметова, э.в.\n|||\nАхметова, Э.В.","gazizova, g.kh.\n|||\nGazizova, G.Kh.","maslennikov, a.v.\n|||\nMaslennikov, A.V.","yashchuk, a.g.\n|||\nYashchuk, A.G.","dautova, l.a.\n|||\nDautova, L.A.","akhmetova, e.v.\n|||\nAkhmetova, E.V."],"author_filter":["газизова, г.х.\n|||\nГазизова, Г.Х.","масленников, а.в.\n|||\nМасленников, А.В.","ящук, а.г.\n|||\nЯщук, А.Г.","даутова, л.а.\n|||\nДаутова, Л.А.","ахметова, э.в.\n|||\nАхметова, Э.В.","gazizova, g.kh.\n|||\nGazizova, G.Kh.","maslennikov, a.v.\n|||\nMaslennikov, A.V.","yashchuk, a.g.\n|||\nYashchuk, A.G.","dautova, l.a.\n|||\nDautova, L.A.","akhmetova, e.v.\n|||\nAkhmetova, E.V."],"dc.contributor.author_hl":["Газизова, Г.Х.","Масленников, А.В.","Ящук, А.Г.","Даутова, Л.А.","Ахметова, Э.В.","Gazizova, G.Kh.","Maslennikov, A.V.","Yashchuk, A.G.","Dautova, L.A.","Akhmetova, E.V."],"dc.contributor.author_mlt":["Газизова, Г.Х.","Масленников, А.В.","Ящук, А.Г.","Даутова, Л.А.","Ахметова, Э.В.","Gazizova, G.Kh.","Maslennikov, A.V.","Yashchuk, A.G.","Dautova, L.A.","Akhmetova, E.V."],"dc.contributor.author":["Газизова, Г.Х.","Масленников, А.В.","Ящук, А.Г.","Даутова, Л.А.","Ахметова, Э.В.","Gazizova, G.Kh.","Maslennikov, A.V.","Yashchuk, A.G.","Dautova, L.A.","Akhmetova, E.V."],"dc.contributor.author_stored":["Газизова, Г.Х.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Масленников, А.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Ящук, А.Г.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Даутова, Л.А.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Ахметова, Э.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Gazizova, G.Kh.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Maslennikov, A.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Yashchuk, A.G.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Dautova, L.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Akhmetova, E.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.ru_RU":["Газизова, Г.Х.","Масленников, А.В.","Ящук, А.Г.","Даутова, Л.А.","Ахметова, Э.В."],"dc.contributor.author.en":["Gazizova, G.Kh.","Maslennikov, A.V.","Yashchuk, A.G.","Dautova, L.A.","Akhmetova, E.V."],"dc.date.accessioned_dt":"2022-10-31T07:48:09Z","dc.date.accessioned":["2022-10-31T07:48:09Z"],"dc.date.available":["2022-10-31T07:48:09Z"],"dateIssued":["2022-01-01"],"dateIssued_keyword":["2022-01-01","2022"],"dateIssued_ac":["2022-01-01\n|||\n2022-01-01","2022"],"dateIssued.year":[2022],"dateIssued.year_sort":"2022","dc.date.issued_dt":"2022-01-01T00:00:00Z","dc.date.issued":["2022-01-01"],"dc.date.issued_stored":["2022-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.description.abstract_hl":["Цель исследования: выявить особенности нарушения гемодинамики у женщин с атрофической формой хронического\nэндометрита (ХЭ).\nМатериал и методы. В исследовании приняли участие 86 пациенток, которые были разделены на две группы: 1-я\nгруппа – 44 пациентки с ХЭ и нарушением гемодинамики в эндометрии, 2-я группа – 42 пациентки с ХЭ без нарушения\nмикроциркуляции в эндометрии. Всем пациенткам были проведены ультразвуковое исследование с допплеровским сканированием на 7-й (+1) день после овуляции и пайпель-биопсия эндометрия с дальнейшим гистологическим и иммуногистохимическим исследованием: определение экспрессии маркеров VEGF, TGF-β, CD 138.\nРезультаты и обсуждение. У пациенток с ХЭ атрофической формы с нарушением микроциркуляции чаще выявлялись: заболевания, передающиеся половым путем, синдром Ашермана, нарушения цикла по типу алгоменореи и гипоменореи, внутриматочные вмешательства в анамнезе.\nЗаключение. По данным иммуногистохимического исследования у пациенток с нарушением гемодинамики статистически понижена экспрессия VEGF и повышена экспрессия TGF-β"],"dc.description.abstract":["Цель исследования: выявить особенности нарушения гемодинамики у женщин с атрофической формой хронического\nэндометрита (ХЭ).\nМатериал и методы. В исследовании приняли участие 86 пациенток, которые были разделены на две группы: 1-я\nгруппа – 44 пациентки с ХЭ и нарушением гемодинамики в эндометрии, 2-я группа – 42 пациентки с ХЭ без нарушения\nмикроциркуляции в эндометрии. Всем пациенткам были проведены ультразвуковое исследование с допплеровским сканированием на 7-й (+1) день после овуляции и пайпель-биопсия эндометрия с дальнейшим гистологическим и иммуногистохимическим исследованием: определение экспрессии маркеров VEGF, TGF-β, CD 138.\nРезультаты и обсуждение. У пациенток с ХЭ атрофической формы с нарушением микроциркуляции чаще выявлялись: заболевания, передающиеся половым путем, синдром Ашермана, нарушения цикла по типу алгоменореи и гипоменореи, внутриматочные вмешательства в анамнезе.\nЗаключение. По данным иммуногистохимического исследования у пациенток с нарушением гемодинамики статистически понижена экспрессия VEGF и повышена экспрессия TGF-β"],"dc.description.abstract.ru_RU":["Цель исследования: выявить особенности нарушения гемодинамики у женщин с атрофической формой хронического\nэндометрита (ХЭ).\nМатериал и методы. В исследовании приняли участие 86 пациенток, которые были разделены на две группы: 1-я\nгруппа – 44 пациентки с ХЭ и нарушением гемодинамики в эндометрии, 2-я группа – 42 пациентки с ХЭ без нарушения\nмикроциркуляции в эндометрии. Всем пациенткам были проведены ультразвуковое исследование с допплеровским сканированием на 7-й (+1) день после овуляции и пайпель-биопсия эндометрия с дальнейшим гистологическим и иммуногистохимическим исследованием: определение экспрессии маркеров VEGF, TGF-β, CD 138.\nРезультаты и обсуждение. У пациенток с ХЭ атрофической формы с нарушением микроциркуляции чаще выявлялись: заболевания, передающиеся половым путем, синдром Ашермана, нарушения цикла по типу алгоменореи и гипоменореи, внутриматочные вмешательства в анамнезе.\nЗаключение. По данным иммуногистохимического исследования у пациенток с нарушением гемодинамики статистически понижена экспрессия VEGF и повышена экспрессия TGF-β"],"dc.identifier.issn":["1999-6209"],"dc.identifier.other":["УДК 618.1"],"dc.identifier.other.ru_RU":["УДК 618.1"],"dc.identifier.uri":["http://hdl.handle.net/123456789/7111"],"dc.publisher":["Издательство \"ФГБОУ ВО БГМУ Минздрава России"],"dc.publisher.ru_RU":["Издательство \"ФГБОУ ВО БГМУ Минздрава России"],"dc.relation.ispartofseries":["Медицинский вестник Башкортостана;т. 17 № 1"],"dc.relation.ispartofseries.ru_RU":["Медицинский вестник Башкортостана;т. 17 № 1"],"subject":["хронический эндометрит","нарушение гемодинамики","chronic endometritis","hemodynamic disorder","VEGF","TGF-β","VEGF","TGF-β"],"subject_keyword":["хронический эндометрит","хронический эндометрит","нарушение гемодинамики","нарушение гемодинамики","chronic endometritis","chronic endometritis","hemodynamic disorder","hemodynamic disorder","VEGF","VEGF","TGF-β","TGF-β","VEGF","VEGF","TGF-β","TGF-β"],"subject_ac":["хронический эндометрит\n|||\nхронический эндометрит","нарушение гемодинамики\n|||\nнарушение гемодинамики","chronic endometritis\n|||\nchronic endometritis","hemodynamic disorder\n|||\nhemodynamic disorder","vegf\n|||\nVEGF","tgf-β\n|||\nTGF-β","vegf\n|||\nVEGF","tgf-β\n|||\nTGF-β"],"subject_tax_0_filter":["хронический эндометрит\n|||\nхронический эндометрит","нарушение гемодинамики\n|||\nнарушение гемодинамики","chronic endometritis\n|||\nchronic endometritis","hemodynamic disorder\n|||\nhemodynamic disorder","vegf\n|||\nVEGF","tgf-β\n|||\nTGF-β","vegf\n|||\nVEGF","tgf-β\n|||\nTGF-β"],"subject_filter":["хронический эндометрит\n|||\nхронический эндометрит","нарушение гемодинамики\n|||\nнарушение гемодинамики","chronic endometritis\n|||\nchronic endometritis","hemodynamic disorder\n|||\nhemodynamic disorder","vegf\n|||\nVEGF","tgf-β\n|||\nTGF-β","vegf\n|||\nVEGF","tgf-β\n|||\nTGF-β"],"dc.subject_mlt":["хронический эндометрит","нарушение гемодинамики","chronic endometritis","hemodynamic disorder","VEGF","TGF-β","VEGF","TGF-β"],"dc.subject":["хронический эндометрит","нарушение гемодинамики","chronic endometritis","hemodynamic disorder","VEGF","TGF-β","VEGF","TGF-β"],"dc.subject.ru_RU":["хронический эндометрит","нарушение гемодинамики","VEGF","TGF-β"],"dc.subject.en":["chronic endometritis","hemodynamic disorder","VEGF","TGF-β"],"title":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"title_keyword":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"title_ac":["особенности гемодинамических нарушений при атрофической форме хронического эндометрита\n|||\nОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","features of hemodynamic disorders in atrophic form of chronic endometritis\n|||\nFEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title_sort":"ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","dc.title_hl":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title_mlt":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА","FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title_stored":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.title.ru_RU":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА"],"dc.title.en":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title.alternative":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS","ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА"],"dc.title.alternative.en":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title.alternative.ru_RU":["ОСОБЕННОСТИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ ПРИ АТРОФИЧЕСКОЙ ФОРМЕ ХРОНИЧЕСКОГО ЭНДОМЕТРИТА"],"dc.type":["Article"],"dc.type.ru_RU":["Article"],"publication_grp":["123456789/7111"],"bi_2_dis_filter":["maslennikov, a.v.\n|||\nMaslennikov, A.V.","газизова, г.х.\n|||\nГазизова, Г.Х.","gazizova, g.kh.\n|||\nGazizova, G.Kh.","akhmetova, e.v.\n|||\nAkhmetova, E.V.","масленников, а.в.\n|||\nМасленников, А.В.","даутова, л.а.\n|||\nДаутова, Л.А.","yashchuk, a.g.\n|||\nYashchuk, A.G.","dautova, l.a.\n|||\nDautova, L.A.","ахметова, э.в.\n|||\nАхметова, Э.В.","ящук, а.г.\n|||\nЯщук, А.Г."],"bi_2_dis_partial":["Ящук, А.Г.","Газизова, Г.Х.","Yashchuk, A.G.","Akhmetova, E.V.","Даутова, Л.А.","Maslennikov, A.V.","Масленников, А.В.","Dautova, L.A.","Ахметова, Э.В.","Gazizova, G.Kh."],"bi_2_dis_value_filter":["Ящук, А.Г.","Газизова, Г.Х.","Yashchuk, A.G.","Akhmetova, E.V.","Даутова, Л.А.","Maslennikov, A.V.","Масленников, А.В.","Dautova, L.A.","Ахметова, Э.В.","Gazizova, G.Kh."],"bi_4_dis_filter":["chronic endometritis\n|||\nchronic endometritis","hemodynamic disorder\n|||\nhemodynamic disorder","tgf-β\n|||\nTGF-β","vegf\n|||\nVEGF","хронический эндометрит\n|||\nхронический эндометрит","нарушение гемодинамики\n|||\nнарушение гемодинамики"],"bi_4_dis_partial":["нарушение гемодинамики","hemodynamic disorder","VEGF","хронический эндометрит","TGF-β","chronic endometritis"],"bi_4_dis_value_filter":["нарушение гемодинамики","hemodynamic disorder","VEGF","хронический эндометрит","TGF-β","chronic endometritis"],"bi_sort_1_sort":"особенности гемодинамических нарушений при атрофической форме хронического эндометрита","bi_sort_2_sort":"2022","bi_sort_3_sort":"2022-10-31T07:48:09Z","read":["g0"],"_version_":1748188609914077184},{"SolrIndexer.lastIndexed":"2024-04-29T09:52:44.861Z","search.uniqueid":"2-7265","search.resourcetype":2,"search.resourceid":7265,"handle":"123456789/8142","location":["m229","l684"],"location.comm":["229"],"location.coll":["684"],"withdrawn":"false","discoverable":"true","author":["Kutlubaev, M.A.","Shagieva, D.R.","Karimova, G.I.","Izmalkova, A.I.","Myachikov, A.V."],"author_keyword":["Kutlubaev, M.A.","Shagieva, D.R.","Karimova, G.I.","Izmalkova, A.I.","Myachikov, A.V."],"author_ac":["kutlubaev, m.a.\n|||\nKutlubaev, M.A.","shagieva, d.r.\n|||\nShagieva, D.R.","karimova, g.i.\n|||\nKarimova, G.I.","izmalkova, a.i.\n|||\nIzmalkova, A.I.","myachikov, a.v.\n|||\nMyachikov, A.V."],"author_filter":["kutlubaev, m.a.\n|||\nKutlubaev, M.A.","shagieva, d.r.\n|||\nShagieva, D.R.","karimova, g.i.\n|||\nKarimova, G.I.","izmalkova, a.i.\n|||\nIzmalkova, A.I.","myachikov, a.v.\n|||\nMyachikov, A.V."],"dc.contributor.author_hl":["Kutlubaev, M.A.","Shagieva, D.R.","Karimova, G.I.","Izmalkova, A.I.","Myachikov, A.V."],"dc.contributor.author_mlt":["Kutlubaev, M.A.","Shagieva, D.R.","Karimova, G.I.","Izmalkova, A.I.","Myachikov, A.V."],"dc.contributor.author":["Kutlubaev, M.A.","Shagieva, D.R.","Karimova, G.I.","Izmalkova, A.I.","Myachikov, A.V."],"dc.contributor.author_stored":["Kutlubaev, M.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Shagieva, D.R.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Karimova, G.I.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Izmalkova, A.I.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Myachikov, A.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.en":["Kutlubaev, M.A.","Shagieva, D.R.","Karimova, G.I.","Izmalkova, A.I.","Myachikov, A.V."],"dc.date.accessioned_dt":"2024-04-29T09:51:44Z","dc.date.accessioned":["2024-04-29T09:51:44Z"],"dc.date.available":["2024-04-29T09:51:44Z"],"dateIssued":["2024-01-01"],"dateIssued_keyword":["2024-01-01","2024"],"dateIssued_ac":["2024-01-01\n|||\n2024-01-01","2024"],"dateIssued.year":[2024],"dateIssued.year_sort":"2024","dc.date.issued_dt":"2024-01-01T00:00:00Z","dc.date.issued":["2024-01-01"],"dc.date.issued_stored":["2024-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.description.abstract_hl":["Pupillometry is an investigation method yielding quantitative assessment of pupil diameter. Pupil size is regulated by structures of the autonomic nervous system (the oculomotor nerve nuclei, the ciliospinal center) and is associated with the level of illumination. However, overlying brain structures, in particular the cortex, acting via the locus coeruleus, pretectal olivary nuclei, and superior colliculi, have modulating effects on pupil reactions which are not related to illumination. Initial pupil diameter and changes in diameter associated with the performance of certain tasks can be used for objective assessment of subjects’ psychoemotional state and cognitive functions. There is evidence of changes in pupil reactions in autism spectrum disorders and depression, as well as in Alzheimer’s disease, Parkinson’s disease, and other organic brain diseases. Further research into pupillometry techniques is needed to identify new areas of application. © Springer Nature Switzerland AG 2024."],"dc.description.abstract":["Pupillometry is an investigation method yielding quantitative assessment of pupil diameter. Pupil size is regulated by structures of the autonomic nervous system (the oculomotor nerve nuclei, the ciliospinal center) and is associated with the level of illumination. However, overlying brain structures, in particular the cortex, acting via the locus coeruleus, pretectal olivary nuclei, and superior colliculi, have modulating effects on pupil reactions which are not related to illumination. Initial pupil diameter and changes in diameter associated with the performance of certain tasks can be used for objective assessment of subjects’ psychoemotional state and cognitive functions. There is evidence of changes in pupil reactions in autism spectrum disorders and depression, as well as in Alzheimer’s disease, Parkinson’s disease, and other organic brain diseases. Further research into pupillometry techniques is needed to identify new areas of application. © Springer Nature Switzerland AG 2024."],"dc.description.abstract.en":["Pupillometry is an investigation method yielding quantitative assessment of pupil diameter. Pupil size is regulated by structures of the autonomic nervous system (the oculomotor nerve nuclei, the ciliospinal center) and is associated with the level of illumination. However, overlying brain structures, in particular the cortex, acting via the locus coeruleus, pretectal olivary nuclei, and superior colliculi, have modulating effects on pupil reactions which are not related to illumination. Initial pupil diameter and changes in diameter associated with the performance of certain tasks can be used for objective assessment of subjects’ psychoemotional state and cognitive functions. There is evidence of changes in pupil reactions in autism spectrum disorders and depression, as well as in Alzheimer’s disease, Parkinson’s disease, and other organic brain diseases. Further research into pupillometry techniques is needed to identify new areas of application. © Springer Nature Switzerland AG 2024."],"dc.doi":["10.1007/s11055-024-01573-2"],"dc.identifier.issn":["0097-0549"],"dc.identifier.uri":["http://hdl.handle.net/123456789/8142"],"dc.language.iso":["en"],"dc.language.iso.en":["en"],"dc.publisher":["Springer"],"dc.publisher.en":["Springer"],"dc.relation.ispartofseries":["Neuroscience and Behavioral Physiology;v. 54 № 1"],"dc.relation.ispartofseries.en":["Neuroscience and Behavioral Physiology;v. 54 № 1"],"subject":["cognitive functions","eye-tracking","photoreaction","psychoemotional disorders","pupil","pupillometry","Scopus"],"subject_keyword":["cognitive functions","cognitive functions","eye-tracking","eye-tracking","photoreaction","photoreaction","psychoemotional disorders","psychoemotional disorders","pupil","pupil","pupillometry","pupillometry","Scopus","Scopus"],"subject_ac":["cognitive functions\n|||\ncognitive functions","eye-tracking\n|||\neye-tracking","photoreaction\n|||\nphotoreaction","psychoemotional disorders\n|||\npsychoemotional disorders","pupil\n|||\npupil","pupillometry\n|||\npupillometry","scopus\n|||\nScopus"],"subject_tax_0_filter":["cognitive functions\n|||\ncognitive functions","eye-tracking\n|||\neye-tracking","photoreaction\n|||\nphotoreaction","psychoemotional disorders\n|||\npsychoemotional disorders","pupil\n|||\npupil","pupillometry\n|||\npupillometry","scopus\n|||\nScopus"],"subject_filter":["cognitive functions\n|||\ncognitive functions","eye-tracking\n|||\neye-tracking","photoreaction\n|||\nphotoreaction","psychoemotional disorders\n|||\npsychoemotional disorders","pupil\n|||\npupil","pupillometry\n|||\npupillometry","scopus\n|||\nScopus"],"dc.subject_mlt":["cognitive functions","eye-tracking","photoreaction","psychoemotional disorders","pupil","pupillometry","Scopus"],"dc.subject":["cognitive functions","eye-tracking","photoreaction","psychoemotional disorders","pupil","pupillometry","Scopus"],"dc.subject.en":["cognitive functions","eye-tracking","photoreaction","psychoemotional disorders","pupil","pupillometry","Scopus"],"title":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"title_keyword":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"title_ac":["pupillometry in the assessment of psychoemotional state and cognitive functions in humans\n|||\nPupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.title_sort":"Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans","dc.title_hl":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.title_mlt":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.title":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.title_stored":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.title.en":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.title.alternative":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.title.alternative.en":["Pupillometry in the Assessment of Psychoemotional State and Cognitive Functions in Humans"],"dc.type":["Article"],"dc.type.en":["Article"],"publication_grp":["123456789/8142"],"bi_2_dis_filter":["kutlubaev, m.a.\n|||\nKutlubaev, M.A.","myachikov, a.v.\n|||\nMyachikov, A.V.","shagieva, d.r.\n|||\nShagieva, D.R.","karimova, g.i.\n|||\nKarimova, G.I.","izmalkova, a.i.\n|||\nIzmalkova, A.I."],"bi_2_dis_partial":["Karimova, G.I.","Shagieva, D.R.","Izmalkova, A.I.","Myachikov, A.V.","Kutlubaev, M.A."],"bi_2_dis_value_filter":["Karimova, G.I.","Shagieva, D.R.","Izmalkova, A.I.","Myachikov, A.V.","Kutlubaev, M.A."],"bi_4_dis_filter":["psychoemotional disorders\n|||\npsychoemotional disorders","pupillometry\n|||\npupillometry","cognitive functions\n|||\ncognitive functions","pupil\n|||\npupil","photoreaction\n|||\nphotoreaction","scopus\n|||\nScopus","eye-tracking\n|||\neye-tracking"],"bi_4_dis_partial":["psychoemotional disorders","cognitive functions","Scopus","pupillometry","eye-tracking","photoreaction","pupil"],"bi_4_dis_value_filter":["psychoemotional disorders","cognitive functions","Scopus","pupillometry","eye-tracking","photoreaction","pupil"],"bi_sort_1_sort":"pupillometry in the assessment of psychoemotional state and cognitive functions in humans","bi_sort_2_sort":"2024","bi_sort_3_sort":"2024-04-29T09:51:44Z","read":["g0"],"_version_":1797662299775827968},{"SolrIndexer.lastIndexed":"2021-04-20T11:26:43.498Z","search.uniqueid":"2-2538","search.resourcetype":2,"search.resourceid":2538,"handle":"123456789/720","location":["m229","l684"],"location.comm":["229"],"location.coll":["684"],"withdrawn":"false","discoverable":"true","author":["Ахмадеева, Г.Н.","Магжанов, Р.В.","Таюпова, Г.Н.","Байтимеров, А.Р.","Хидиятова, И.М.","Akhmadeeva, G.N.","Magzhanov, R.V.","Tayupova, G.N.","Bajtimerov, A.R.","Hidijatova, I.M."],"author_keyword":["Ахмадеева, Г.Н.","Магжанов, Р.В.","Таюпова, Г.Н.","Байтимеров, А.Р.","Хидиятова, И.М.","Akhmadeeva, G.N.","Magzhanov, R.V.","Tayupova, G.N.","Bajtimerov, A.R.","Hidijatova, I.M."],"author_ac":["ахмадеева, г.н.\n|||\nАхмадеева, Г.Н.","магжанов, р.в.\n|||\nМагжанов, Р.В.","таюпова, г.н.\n|||\nТаюпова, Г.Н.","байтимеров, а.р.\n|||\nБайтимеров, А.Р.","хидиятова, и.м.\n|||\nХидиятова, И.М.","akhmadeeva, g.n.\n|||\nAkhmadeeva, G.N.","magzhanov, r.v.\n|||\nMagzhanov, R.V.","tayupova, g.n.\n|||\nTayupova, G.N.","bajtimerov, a.r.\n|||\nBajtimerov, A.R.","hidijatova, i.m.\n|||\nHidijatova, I.M."],"author_filter":["ахмадеева, г.н.\n|||\nАхмадеева, Г.Н.","магжанов, р.в.\n|||\nМагжанов, Р.В.","таюпова, г.н.\n|||\nТаюпова, Г.Н.","байтимеров, а.р.\n|||\nБайтимеров, А.Р.","хидиятова, и.м.\n|||\nХидиятова, И.М.","akhmadeeva, g.n.\n|||\nAkhmadeeva, G.N.","magzhanov, r.v.\n|||\nMagzhanov, R.V.","tayupova, g.n.\n|||\nTayupova, G.N.","bajtimerov, a.r.\n|||\nBajtimerov, A.R.","hidijatova, i.m.\n|||\nHidijatova, I.M."],"dc.contributor.author_hl":["Ахмадеева, Г.Н.","Магжанов, Р.В.","Таюпова, Г.Н.","Байтимеров, А.Р.","Хидиятова, И.М.","Akhmadeeva, G.N.","Magzhanov, R.V.","Tayupova, G.N.","Bajtimerov, A.R.","Hidijatova, I.M."],"dc.contributor.author_mlt":["Ахмадеева, Г.Н.","Магжанов, Р.В.","Таюпова, Г.Н.","Байтимеров, А.Р.","Хидиятова, И.М.","Akhmadeeva, G.N.","Magzhanov, R.V.","Tayupova, G.N.","Bajtimerov, A.R.","Hidijatova, I.M."],"dc.contributor.author":["Ахмадеева, Г.Н.","Магжанов, Р.В.","Таюпова, Г.Н.","Байтимеров, А.Р.","Хидиятова, И.М.","Akhmadeeva, G.N.","Magzhanov, R.V.","Tayupova, G.N.","Bajtimerov, A.R.","Hidijatova, I.M."],"dc.contributor.author_stored":["Ахмадеева, Г.Н.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru","Магжанов, Р.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru","Таюпова, Г.Н.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru","Байтимеров, А.Р.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru","Хидиятова, И.М.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru","Akhmadeeva, G.N.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Magzhanov, R.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Tayupova, G.N.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Bajtimerov, A.R.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Hidijatova, I.M.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.ru":["Ахмадеева, Г.Н.","Магжанов, Р.В.","Таюпова, Г.Н.","Байтимеров, А.Р.","Хидиятова, И.М."],"dc.contributor.author.en":["Akhmadeeva, G.N.","Magzhanov, R.V.","Tayupova, G.N.","Bajtimerov, A.R.","Hidijatova, I.M."],"dc.date.accessioned_dt":"2018-03-13T09:54:01Z","dc.date.accessioned":["2018-03-13T09:54:01Z"],"dc.date.available":["2018-03-13T09:54:01Z"],"dateIssued":["2017-01-01"],"dateIssued_keyword":["2017-01-01","2017"],"dateIssued_ac":["2017-01-01\n|||\n2017-01-01","2017"],"dateIssued.year":[2017],"dateIssued.year_sort":"2017","dc.date.issued_dt":"2017-01-01T00:00:00Z","dc.date.issued":["2017-01-01"],"dc.date.issued_stored":["2017-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.identifier.other":["DOI 10.17116/jnevro20171171254-58"],"dc.identifier.uri":["http://repo.bashgmu.ru/xmlui/handle/123456789/720","http://hdl.handle.net/123456789/720"],"dc.description.abstract_hl":["В обзоре изложены данные последних мировых исследований тревожно-депрессивных расстройств у пациентов с\nболезнью Паркинсона (БП), представлены их характеристика и эпидемиология, особенности патогенеза, клинические\nособенности, а также современные методы диагностики и лечения. Депрессия встречается в среднем у 40—50% пациентов\nс БП, тревога — у 17—43% пациентов. Для лечения депрессии лишь один препарат — прамипексол (агонист дофаминовых\nрецепторов), рекомендован к применению. Еще два, нортриптилин и дезипрамин, относящиеся к группе трициклических\nантидепрессантов, считаются «вероятно» эффективными. Для лечения тревоги пока не существует четких рекомендаций.\nВ целом методы терапии тревожно-депрессивных нарушений при БП изучены недостаточно, что предопределяет\nпроведение широкомасштабных исследований в будущем.","This review presents the most recent data of worldwide research on anxiety and depressive disorders in patients with Parkinson’s\ndisease. Their characteristics and epidemiology, pathogenetic and clinical features, methods of diagnosis and treatment are\npresented. Depression occurs in 40—50% of patients with PD, anxiety in 17—43% of patients. Pramipexole, a dopamine agonist,\nis only one drug recommended for depression treatment. Nortriptyline and desipramine, belonging to the group of tricyclic\nantidepressants (TCAs), are considered to be possibly effective. There are no clear recommendations for treatment of anxiety. In\ngeneral, methods of therapy of anxiety and depressive disorders in PD are not well understood which determines the conduct of\nlarge-scale studies in the future."],"dc.description.abstract":["В обзоре изложены данные последних мировых исследований тревожно-депрессивных расстройств у пациентов с\nболезнью Паркинсона (БП), представлены их характеристика и эпидемиология, особенности патогенеза, клинические\nособенности, а также современные методы диагностики и лечения. Депрессия встречается в среднем у 40—50% пациентов\nс БП, тревога — у 17—43% пациентов. Для лечения депрессии лишь один препарат — прамипексол (агонист дофаминовых\nрецепторов), рекомендован к применению. Еще два, нортриптилин и дезипрамин, относящиеся к группе трициклических\nантидепрессантов, считаются «вероятно» эффективными. Для лечения тревоги пока не существует четких рекомендаций.\nВ целом методы терапии тревожно-депрессивных нарушений при БП изучены недостаточно, что предопределяет\nпроведение широкомасштабных исследований в будущем.","This review presents the most recent data of worldwide research on anxiety and depressive disorders in patients with Parkinson’s\ndisease. Their characteristics and epidemiology, pathogenetic and clinical features, methods of diagnosis and treatment are\npresented. Depression occurs in 40—50% of patients with PD, anxiety in 17—43% of patients. Pramipexole, a dopamine agonist,\nis only one drug recommended for depression treatment. Nortriptyline and desipramine, belonging to the group of tricyclic\nantidepressants (TCAs), are considered to be possibly effective. There are no clear recommendations for treatment of anxiety. In\ngeneral, methods of therapy of anxiety and depressive disorders in PD are not well understood which determines the conduct of\nlarge-scale studies in the future."],"dc.description.abstract.ru":["В обзоре изложены данные последних мировых исследований тревожно-депрессивных расстройств у пациентов с\nболезнью Паркинсона (БП), представлены их характеристика и эпидемиология, особенности патогенеза, клинические\nособенности, а также современные методы диагностики и лечения. Депрессия встречается в среднем у 40—50% пациентов\nс БП, тревога — у 17—43% пациентов. Для лечения депрессии лишь один препарат — прамипексол (агонист дофаминовых\nрецепторов), рекомендован к применению. Еще два, нортриптилин и дезипрамин, относящиеся к группе трициклических\nантидепрессантов, считаются «вероятно» эффективными. Для лечения тревоги пока не существует четких рекомендаций.\nВ целом методы терапии тревожно-депрессивных нарушений при БП изучены недостаточно, что предопределяет\nпроведение широкомасштабных исследований в будущем."],"dc.description.abstract.en":["This review presents the most recent data of worldwide research on anxiety and depressive disorders in patients with Parkinson’s\ndisease. Their characteristics and epidemiology, pathogenetic and clinical features, methods of diagnosis and treatment are\npresented. Depression occurs in 40—50% of patients with PD, anxiety in 17—43% of patients. Pramipexole, a dopamine agonist,\nis only one drug recommended for depression treatment. Nortriptyline and desipramine, belonging to the group of tricyclic\nantidepressants (TCAs), are considered to be possibly effective. There are no clear recommendations for treatment of anxiety. In\ngeneral, methods of therapy of anxiety and depressive disorders in PD are not well understood which determines the conduct of\nlarge-scale studies in the future."],"dc.relation.ispartofseries":["Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova;117(1)"],"subject":["болезнь Паркинсона","депрессия","тревожность","Parkinson’s disease","cognitive disorders","dementia","anxiety","depression"],"subject_keyword":["болезнь Паркинсона","болезнь Паркинсона","депрессия","депрессия","тревожность","тревожность","Parkinson’s disease","Parkinson’s disease","cognitive disorders","cognitive disorders","dementia","dementia","anxiety","anxiety","depression","depression"],"subject_ac":["болезнь паркинсона\n|||\nболезнь Паркинсона","депрессия\n|||\nдепрессия","тревожность\n|||\nтревожность","parkinson’s disease\n|||\nParkinson’s disease","cognitive disorders\n|||\ncognitive disorders","dementia\n|||\ndementia","anxiety\n|||\nanxiety","depression\n|||\ndepression"],"subject_tax_0_filter":["болезнь паркинсона\n|||\nболезнь Паркинсона","депрессия\n|||\nдепрессия","тревожность\n|||\nтревожность","parkinson’s disease\n|||\nParkinson’s disease","cognitive disorders\n|||\ncognitive disorders","dementia\n|||\ndementia","anxiety\n|||\nanxiety","depression\n|||\ndepression"],"subject_filter":["болезнь паркинсона\n|||\nболезнь Паркинсона","депрессия\n|||\nдепрессия","тревожность\n|||\nтревожность","parkinson’s disease\n|||\nParkinson’s disease","cognitive disorders\n|||\ncognitive disorders","dementia\n|||\ndementia","anxiety\n|||\nanxiety","depression\n|||\ndepression"],"dc.subject_mlt":["болезнь Паркинсона","депрессия","тревожность","Parkinson’s disease","cognitive disorders","dementia","anxiety","depression"],"dc.subject":["болезнь Паркинсона","депрессия","тревожность","Parkinson’s disease","cognitive disorders","dementia","anxiety","depression"],"dc.subject.ru":["болезнь Паркинсона","депрессия","тревожность"],"dc.subject.en":["Parkinson’s disease","cognitive disorders","dementia","anxiety","depression"],"title":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"title_keyword":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"title_ac":["депрессия и тревожность при болезни паркинсона\n|||\nДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"dc.title_sort":"ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА","dc.title_hl":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"dc.title_mlt":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"dc.title":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"dc.title_stored":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru"],"dc.title.ru":["ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНА"],"dc.title.alternative":["ANXIETY AND DEPRESSIVE DISORDERS IN PARKINSON’S DISEASE"],"dc.title.alternative.en":["ANXIETY AND DEPRESSIVE DISORDERS IN PARKINSON’S DISEASE"],"dc.type":["Article"],"dc.type.ru":["Article"],"publication_grp":["123456789/720"],"bi_2_dis_filter":["байтимеров, а.р.\n|||\nБайтимеров, А.Р.","хидиятова, и.м.\n|||\nХидиятова, И.М.","tayupova, g.n.\n|||\nTayupova, G.N.","ахмадеева, г.н.\n|||\nАхмадеева, Г.Н.","bajtimerov, a.r.\n|||\nBajtimerov, A.R.","magzhanov, r.v.\n|||\nMagzhanov, R.V.","hidijatova, i.m.\n|||\nHidijatova, I.M.","магжанов, р.в.\n|||\nМагжанов, Р.В.","таюпова, г.н.\n|||\nТаюпова, Г.Н.","akhmadeeva, g.n.\n|||\nAkhmadeeva, G.N."],"bi_2_dis_partial":["Хидиятова, И.М.","Magzhanov, R.V.","Магжанов, Р.В.","Ахмадеева, Г.Н.","Таюпова, Г.Н.","Байтимеров, А.Р.","Bajtimerov, A.R.","Tayupova, G.N.","Akhmadeeva, G.N.","Hidijatova, I.M."],"bi_2_dis_value_filter":["Хидиятова, И.М.","Magzhanov, R.V.","Магжанов, Р.В.","Ахмадеева, Г.Н.","Таюпова, Г.Н.","Байтимеров, А.Р.","Bajtimerov, A.R.","Tayupova, G.N.","Akhmadeeva, G.N.","Hidijatova, I.M."],"bi_4_dis_filter":["cognitive disorders\n|||\ncognitive disorders","depression\n|||\ndepression","dementia\n|||\ndementia","болезнь паркинсона\n|||\nболезнь Паркинсона","тревожность\n|||\nтревожность","parkinson’s disease\n|||\nParkinson’s disease","anxiety\n|||\nanxiety","депрессия\n|||\nдепрессия"],"bi_4_dis_partial":["депрессия","тревожность","anxiety","dementia","depression","Parkinson’s disease","cognitive disorders","болезнь Паркинсона"],"bi_4_dis_value_filter":["депрессия","тревожность","anxiety","dementia","depression","Parkinson’s disease","cognitive disorders","болезнь Паркинсона"],"bi_sort_1_sort":"депрессия и тревожность при болезни паркинсона","bi_sort_2_sort":"2017","bi_sort_3_sort":"2018-03-13T09:54:01Z","read":["g0"],"_version_":1697558564446404608},{"SolrIndexer.lastIndexed":"2021-04-20T11:27:16.481Z","search.uniqueid":"2-4604","search.resourcetype":2,"search.resourceid":4604,"handle":"123456789/5508","location":["m229","l684"],"location.comm":["229"],"location.coll":["684"],"withdrawn":"false","discoverable":"true","author":["Asadi-Pooya, A.A.","Brigo, F.","Lattanzi, S.","D'Alessio, L.","Daza-Restrepo, A.","Calle-Lopez, Y.","Hingray, C.","Alsaadi, T.","Mesraoua, B.","Gigineishvili, D.","Kutlubaev, M.A.","Yaghmoor, B.E.","Aljandeel, G.B.","Sarudiasnky, M.","Scévola, L.","Contreras, G.","Lozada, M.E."],"author_keyword":["Asadi-Pooya, A.A.","Brigo, F.","Lattanzi, S.","D'Alessio, L.","Daza-Restrepo, A.","Calle-Lopez, Y.","Hingray, C.","Alsaadi, T.","Mesraoua, B.","Gigineishvili, D.","Kutlubaev, M.A.","Yaghmoor, B.E.","Aljandeel, G.B.","Sarudiasnky, M.","Scévola, L.","Contreras, G.","Lozada, M.E."],"author_ac":["asadi-pooya, a.a.\n|||\nAsadi-Pooya, A.A.","brigo, f.\n|||\nBrigo, F.","lattanzi, s.\n|||\nLattanzi, S.","d'alessio, l.\n|||\nD'Alessio, L.","daza-restrepo, a.\n|||\nDaza-Restrepo, A.","calle-lopez, y.\n|||\nCalle-Lopez, Y.","hingray, c.\n|||\nHingray, C.","alsaadi, t.\n|||\nAlsaadi, T.","mesraoua, b.\n|||\nMesraoua, B.","gigineishvili, d.\n|||\nGigineishvili, D.","kutlubaev, m.a.\n|||\nKutlubaev, M.A.","yaghmoor, b.e.\n|||\nYaghmoor, B.E.","aljandeel, g.b.\n|||\nAljandeel, G.B.","sarudiasnky, m.\n|||\nSarudiasnky, M.","scévola, l.\n|||\nScévola, L.","contreras, g.\n|||\nContreras, G.","lozada, m.e.\n|||\nLozada, M.E."],"author_filter":["asadi-pooya, a.a.\n|||\nAsadi-Pooya, A.A.","brigo, f.\n|||\nBrigo, F.","lattanzi, s.\n|||\nLattanzi, S.","d'alessio, l.\n|||\nD'Alessio, L.","daza-restrepo, a.\n|||\nDaza-Restrepo, A.","calle-lopez, y.\n|||\nCalle-Lopez, Y.","hingray, c.\n|||\nHingray, C.","alsaadi, t.\n|||\nAlsaadi, T.","mesraoua, b.\n|||\nMesraoua, B.","gigineishvili, d.\n|||\nGigineishvili, D.","kutlubaev, m.a.\n|||\nKutlubaev, M.A.","yaghmoor, b.e.\n|||\nYaghmoor, B.E.","aljandeel, g.b.\n|||\nAljandeel, G.B.","sarudiasnky, m.\n|||\nSarudiasnky, M.","scévola, l.\n|||\nScévola, L.","contreras, g.\n|||\nContreras, G.","lozada, m.e.\n|||\nLozada, M.E."],"dc.contributor.author_hl":["Asadi-Pooya, A.A.","Brigo, F.","Lattanzi, S.","D'Alessio, L.","Daza-Restrepo, A.","Calle-Lopez, Y.","Hingray, C.","Alsaadi, T.","Mesraoua, B.","Gigineishvili, D.","Kutlubaev, M.A.","Yaghmoor, B.E.","Aljandeel, G.B.","Sarudiasnky, M.","Scévola, L.","Contreras, G.","Lozada, M.E."],"dc.contributor.author_mlt":["Asadi-Pooya, A.A.","Brigo, F.","Lattanzi, S.","D'Alessio, L.","Daza-Restrepo, A.","Calle-Lopez, Y.","Hingray, C.","Alsaadi, T.","Mesraoua, B.","Gigineishvili, D.","Kutlubaev, M.A.","Yaghmoor, B.E.","Aljandeel, G.B.","Sarudiasnky, M.","Scévola, L.","Contreras, G.","Lozada, M.E."],"dc.contributor.author":["Asadi-Pooya, A.A.","Brigo, F.","Lattanzi, S.","D'Alessio, L.","Daza-Restrepo, A.","Calle-Lopez, Y.","Hingray, C.","Alsaadi, T.","Mesraoua, B.","Gigineishvili, D.","Kutlubaev, M.A.","Yaghmoor, B.E.","Aljandeel, G.B.","Sarudiasnky, M.","Scévola, L.","Contreras, G.","Lozada, M.E."],"dc.contributor.author_stored":["Asadi-Pooya, A.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Brigo, F.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Lattanzi, S.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","D'Alessio, L.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Daza-Restrepo, A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Calle-Lopez, Y.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Hingray, C.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Alsaadi, T.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Mesraoua, B.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Gigineishvili, D.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Kutlubaev, M.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Yaghmoor, B.E.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Aljandeel, G.B.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Sarudiasnky, M.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Scévola, L.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Contreras, G.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Lozada, M.E.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.en":["Asadi-Pooya, A.A.","Brigo, F.","Lattanzi, S.","D'Alessio, L.","Daza-Restrepo, A.","Calle-Lopez, Y.","Hingray, C.","Alsaadi, T.","Mesraoua, B.","Gigineishvili, D.","Kutlubaev, M.A.","Yaghmoor, B.E.","Aljandeel, G.B.","Sarudiasnky, M.","Scévola, L.","Contreras, G.","Lozada, M.E."],"dc.date.accessioned_dt":"2021-01-27T09:20:26Z","dc.date.accessioned":["2021-01-27T09:20:26Z"],"dc.date.available":["2021-01-27T09:20:26Z"],"dateIssued":["2021-01-01"],"dateIssued_keyword":["2021-01-01","2021"],"dateIssued_ac":["2021-01-01\n|||\n2021-01-01","2021"],"dateIssued.year":[2021],"dateIssued.year_sort":"2021","dc.date.issued_dt":"2021-01-01T00:00:00Z","dc.date.issued":["2021-01-01"],"dc.date.issued_stored":["2021-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.identifier.issn":["1525-5050"],"dc.identifier.uri":["http://hdl.handle.net/123456789/5508"],"dc.description.abstract_hl":["Objectives: In this international study, we aimed to investigate the opinions of physicians dealing with patients with functional seizures (FS) worldwide on working restrictions and disability benefits eligibility. Methods: International online survey of neurologists/mental health professionals from Argentina, Venezuela, Colombia, Italy, France, Iran, Iraq, United Arab Emirates (UAE), Qatar, Saudi Arabia, Georgia, and Russia. Results: Six hundred and twenty-seven physicians from 12 countries participated in the study. Working as a neurologist was a predictor to think that patients with FS should not be counseled to avoid performing all jobs or professions as long as they have active disease (OR: 0.46; 95% CI: 0.30 to 0.68; p < 0.001). Having managed more than 200 patients was associated with the opinion that patients should not be counseled to avoid performing any type of work (OR: 2.17; 95% CI: 1.02 to 4.59; p = 0.043). Working as a psychiatrist/psychologist was associated with the idea that patients with FS should be qualified for disability benefits (OR: 1.97; 95% CI: 1.21–3.21; p = 0.006), and receive these benefits lifelong (OR: 0.43; 95% CI: 0.22–0.84; p = 0.014). Conclusion: Neurologists and mental health professionals have different attitudes and opinions toward working restrictions and disability benefits for patients with FS. Further studies should investigate the reasons for these differences, and propose solutions to avoid discrimination and unequal access to employment and disability benefits."],"dc.description.abstract":["Objectives: In this international study, we aimed to investigate the opinions of physicians dealing with patients with functional seizures (FS) worldwide on working restrictions and disability benefits eligibility. Methods: International online survey of neurologists/mental health professionals from Argentina, Venezuela, Colombia, Italy, France, Iran, Iraq, United Arab Emirates (UAE), Qatar, Saudi Arabia, Georgia, and Russia. Results: Six hundred and twenty-seven physicians from 12 countries participated in the study. Working as a neurologist was a predictor to think that patients with FS should not be counseled to avoid performing all jobs or professions as long as they have active disease (OR: 0.46; 95% CI: 0.30 to 0.68; p < 0.001). Having managed more than 200 patients was associated with the opinion that patients should not be counseled to avoid performing any type of work (OR: 2.17; 95% CI: 1.02 to 4.59; p = 0.043). Working as a psychiatrist/psychologist was associated with the idea that patients with FS should be qualified for disability benefits (OR: 1.97; 95% CI: 1.21–3.21; p = 0.006), and receive these benefits lifelong (OR: 0.43; 95% CI: 0.22–0.84; p = 0.014). Conclusion: Neurologists and mental health professionals have different attitudes and opinions toward working restrictions and disability benefits for patients with FS. Further studies should investigate the reasons for these differences, and propose solutions to avoid discrimination and unequal access to employment and disability benefits."],"dc.description.abstract.en":["Objectives: In this international study, we aimed to investigate the opinions of physicians dealing with patients with functional seizures (FS) worldwide on working restrictions and disability benefits eligibility. Methods: International online survey of neurologists/mental health professionals from Argentina, Venezuela, Colombia, Italy, France, Iran, Iraq, United Arab Emirates (UAE), Qatar, Saudi Arabia, Georgia, and Russia. Results: Six hundred and twenty-seven physicians from 12 countries participated in the study. Working as a neurologist was a predictor to think that patients with FS should not be counseled to avoid performing all jobs or professions as long as they have active disease (OR: 0.46; 95% CI: 0.30 to 0.68; p < 0.001). Having managed more than 200 patients was associated with the opinion that patients should not be counseled to avoid performing any type of work (OR: 2.17; 95% CI: 1.02 to 4.59; p = 0.043). Working as a psychiatrist/psychologist was associated with the idea that patients with FS should be qualified for disability benefits (OR: 1.97; 95% CI: 1.21–3.21; p = 0.006), and receive these benefits lifelong (OR: 0.43; 95% CI: 0.22–0.84; p = 0.014). Conclusion: Neurologists and mental health professionals have different attitudes and opinions toward working restrictions and disability benefits for patients with FS. Further studies should investigate the reasons for these differences, and propose solutions to avoid discrimination and unequal access to employment and disability benefits."],"dc.description.sponsorship":["Shiraz University of Medical Sciences supported this study."],"dc.description.sponsorship.en":["Shiraz University of Medical Sciences supported this study."],"dc.language.iso":["en"],"dc.language.iso.en":["en"],"dc.publisher":["Academic Press Inc."],"dc.publisher.en":["Academic Press Inc."],"dc.relation.ispartofseries":["Epilepsy and Behavior;"],"dc.relation.ispartofseries.en":["Epilepsy and Behavior;"],"subject":["Disability","Dissociative","PNES","Psychogenic","Seizure","Scopus","Web of Science"],"subject_keyword":["Disability","Disability","Dissociative","Dissociative","PNES","PNES","Psychogenic","Psychogenic","Seizure","Seizure","Scopus","Scopus","Web of Science","Web of Science"],"subject_ac":["disability\n|||\nDisability","dissociative\n|||\nDissociative","pnes\n|||\nPNES","psychogenic\n|||\nPsychogenic","seizure\n|||\nSeizure","scopus\n|||\nScopus","web of science\n|||\nWeb of Science"],"subject_tax_0_filter":["disability\n|||\nDisability","dissociative\n|||\nDissociative","pnes\n|||\nPNES","psychogenic\n|||\nPsychogenic","seizure\n|||\nSeizure","scopus\n|||\nScopus","web of science\n|||\nWeb of Science"],"subject_filter":["disability\n|||\nDisability","dissociative\n|||\nDissociative","pnes\n|||\nPNES","psychogenic\n|||\nPsychogenic","seizure\n|||\nSeizure","scopus\n|||\nScopus","web of science\n|||\nWeb of Science"],"dc.subject_mlt":["Disability","Dissociative","PNES","Psychogenic","Seizure","Scopus","Web of Science"],"dc.subject":["Disability","Dissociative","PNES","Psychogenic","Seizure","Scopus","Web of Science"],"dc.subject.en":["Disability","Dissociative","PNES","Psychogenic","Seizure","Scopus","Web of Science"],"title":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"title_keyword":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"title_ac":["working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: an international survey of physicians’ opinions\n|||\nWorking restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.title_sort":"Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions","dc.title_hl":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.title_mlt":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.title":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.title_stored":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.title.en":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.title.alternative":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.title.alternative.en":["Working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: An international survey of physicians’ opinions"],"dc.type":["Article"],"dc.type.en":["Article"],"dc.doi":["10.1016/j.yebeh.2020.107678"],"dc.doi.en":["10.1016/j.yebeh.2020.107678"],"publication_grp":["123456789/5508"],"bi_2_dis_filter":["daza-restrepo, a.\n|||\nDaza-Restrepo, A.","yaghmoor, b.e.\n|||\nYaghmoor, B.E.","scévola, l.\n|||\nScévola, L.","asadi-pooya, a.a.\n|||\nAsadi-Pooya, A.A.","alsaadi, t.\n|||\nAlsaadi, T.","gigineishvili, d.\n|||\nGigineishvili, D.","sarudiasnky, m.\n|||\nSarudiasnky, M.","contreras, g.\n|||\nContreras, G.","lozada, m.e.\n|||\nLozada, M.E.","mesraoua, b.\n|||\nMesraoua, B.","calle-lopez, y.\n|||\nCalle-Lopez, Y.","kutlubaev, m.a.\n|||\nKutlubaev, M.A.","lattanzi, s.\n|||\nLattanzi, S.","d'alessio, l.\n|||\nD'Alessio, L.","hingray, c.\n|||\nHingray, C.","aljandeel, g.b.\n|||\nAljandeel, G.B.","brigo, f.\n|||\nBrigo, F."],"bi_2_dis_partial":["Calle-Lopez, Y.","Alsaadi, T.","Daza-Restrepo, A.","Yaghmoor, B.E.","Aljandeel, G.B.","Lozada, M.E.","Mesraoua, B.","Sarudiasnky, M.","Asadi-Pooya, A.A.","D'Alessio, L.","Brigo, F.","Hingray, C.","Scévola, L.","Lattanzi, S.","Contreras, G.","Gigineishvili, D.","Kutlubaev, M.A."],"bi_2_dis_value_filter":["Calle-Lopez, Y.","Alsaadi, T.","Daza-Restrepo, A.","Yaghmoor, B.E.","Aljandeel, G.B.","Lozada, M.E.","Mesraoua, B.","Sarudiasnky, M.","Asadi-Pooya, A.A.","D'Alessio, L.","Brigo, F.","Hingray, C.","Scévola, L.","Lattanzi, S.","Contreras, G.","Gigineishvili, D.","Kutlubaev, M.A."],"bi_4_dis_filter":["dissociative\n|||\nDissociative","pnes\n|||\nPNES","scopus\n|||\nScopus","disability\n|||\nDisability","psychogenic\n|||\nPsychogenic","seizure\n|||\nSeizure","web of science\n|||\nWeb of Science"],"bi_4_dis_partial":["Disability","Web of Science","Scopus","PNES","Psychogenic","Seizure","Dissociative"],"bi_4_dis_value_filter":["Disability","Web of Science","Scopus","PNES","Psychogenic","Seizure","Dissociative"],"bi_sort_1_sort":"working restrictions and disability benefits eligibility in patients with functional (psychogenic) seizures: an international survey of physicians’ opinions","bi_sort_2_sort":"2021","bi_sort_3_sort":"2021-01-27T09:20:26Z","read":["g0"],"_version_":1697558599029489664},{"SolrIndexer.lastIndexed":"2021-12-08T11:29:35.835Z","search.uniqueid":"2-5305","search.resourcetype":2,"search.resourceid":5305,"handle":"123456789/6215","location":["m229","l684"],"location.comm":["229"],"location.coll":["684"],"withdrawn":"false","discoverable":"true","author":["Boyko, A.N.","Bakhtiyarova, K.Z.","Brylev, L.V.","Zakharova, M.N.","Kasatkin, D.S.","Korobko, D.S.","Kotov, S.V.","Krasnov, V.S.","Malkova, N.A.","Popova, E.V.","Sivertseva, S.A.","Simaniv, T.O.","Sokolova, A.A.","Totolyan, N.A.","Trushnikova, T.N.","Khabirov, F.A.","Khachanova, N.V."],"author_keyword":["Boyko, A.N.","Bakhtiyarova, K.Z.","Brylev, L.V.","Zakharova, M.N.","Kasatkin, D.S.","Korobko, D.S.","Kotov, S.V.","Krasnov, V.S.","Malkova, N.A.","Popova, E.V.","Sivertseva, S.A.","Simaniv, T.O.","Sokolova, A.A.","Totolyan, N.A.","Trushnikova, T.N.","Khabirov, F.A.","Khachanova, N.V."],"author_ac":["boyko, a.n.\n|||\nBoyko, A.N.","bakhtiyarova, k.z.\n|||\nBakhtiyarova, K.Z.","brylev, l.v.\n|||\nBrylev, L.V.","zakharova, m.n.\n|||\nZakharova, M.N.","kasatkin, d.s.\n|||\nKasatkin, D.S.","korobko, d.s.\n|||\nKorobko, D.S.","kotov, s.v.\n|||\nKotov, S.V.","krasnov, v.s.\n|||\nKrasnov, V.S.","malkova, n.a.\n|||\nMalkova, N.A.","popova, e.v.\n|||\nPopova, E.V.","sivertseva, s.a.\n|||\nSivertseva, S.A.","simaniv, t.o.\n|||\nSimaniv, T.O.","sokolova, a.a.\n|||\nSokolova, A.A.","totolyan, n.a.\n|||\nTotolyan, N.A.","trushnikova, t.n.\n|||\nTrushnikova, T.N.","khabirov, f.a.\n|||\nKhabirov, F.A.","khachanova, n.v.\n|||\nKhachanova, N.V."],"author_filter":["boyko, a.n.\n|||\nBoyko, A.N.","bakhtiyarova, k.z.\n|||\nBakhtiyarova, K.Z.","brylev, l.v.\n|||\nBrylev, L.V.","zakharova, m.n.\n|||\nZakharova, M.N.","kasatkin, d.s.\n|||\nKasatkin, D.S.","korobko, d.s.\n|||\nKorobko, D.S.","kotov, s.v.\n|||\nKotov, S.V.","krasnov, v.s.\n|||\nKrasnov, V.S.","malkova, n.a.\n|||\nMalkova, N.A.","popova, e.v.\n|||\nPopova, E.V.","sivertseva, s.a.\n|||\nSivertseva, S.A.","simaniv, t.o.\n|||\nSimaniv, T.O.","sokolova, a.a.\n|||\nSokolova, A.A.","totolyan, n.a.\n|||\nTotolyan, N.A.","trushnikova, t.n.\n|||\nTrushnikova, T.N.","khabirov, f.a.\n|||\nKhabirov, F.A.","khachanova, n.v.\n|||\nKhachanova, N.V."],"dc.contributor.author_hl":["Boyko, A.N.","Bakhtiyarova, K.Z.","Brylev, L.V.","Zakharova, M.N.","Kasatkin, D.S.","Korobko, D.S.","Kotov, S.V.","Krasnov, V.S.","Malkova, N.A.","Popova, E.V.","Sivertseva, S.A.","Simaniv, T.O.","Sokolova, A.A.","Totolyan, N.A.","Trushnikova, T.N.","Khabirov, F.A.","Khachanova, N.V."],"dc.contributor.author_mlt":["Boyko, A.N.","Bakhtiyarova, K.Z.","Brylev, L.V.","Zakharova, M.N.","Kasatkin, D.S.","Korobko, D.S.","Kotov, S.V.","Krasnov, V.S.","Malkova, N.A.","Popova, E.V.","Sivertseva, S.A.","Simaniv, T.O.","Sokolova, A.A.","Totolyan, N.A.","Trushnikova, T.N.","Khabirov, F.A.","Khachanova, N.V."],"dc.contributor.author":["Boyko, A.N.","Bakhtiyarova, K.Z.","Brylev, L.V.","Zakharova, M.N.","Kasatkin, D.S.","Korobko, D.S.","Kotov, S.V.","Krasnov, V.S.","Malkova, N.A.","Popova, E.V.","Sivertseva, S.A.","Simaniv, T.O.","Sokolova, A.A.","Totolyan, N.A.","Trushnikova, T.N.","Khabirov, F.A.","Khachanova, N.V."],"dc.contributor.author_stored":["Boyko, A.N.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Bakhtiyarova, K.Z.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Brylev, L.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Zakharova, M.N.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Kasatkin, D.S.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Korobko, D.S.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Kotov, S.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Krasnov, V.S.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Malkova, N.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Popova, E.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Sivertseva, S.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Simaniv, T.O.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Sokolova, A.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Totolyan, N.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Trushnikova, T.N.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Khabirov, F.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Khachanova, N.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.en":["Boyko, A.N.","Bakhtiyarova, K.Z.","Brylev, L.V.","Zakharova, M.N.","Kasatkin, D.S.","Korobko, D.S.","Kotov, S.V.","Krasnov, V.S.","Malkova, N.A.","Popova, E.V.","Sivertseva, S.A.","Simaniv, T.O.","Sokolova, A.A.","Totolyan, N.A.","Trushnikova, T.N.","Khabirov, F.A.","Khachanova, N.V."],"dc.date.accessioned_dt":"2021-12-08T11:27:00Z","dc.date.accessioned":["2021-12-08T11:27:00Z"],"dc.date.available":["2021-12-08T11:27:00Z"],"dateIssued":["2021-01-01"],"dateIssued_keyword":["2021-01-01","2021"],"dateIssued_ac":["2021-01-01\n|||\n2021-01-01","2021"],"dateIssued.year":[2021],"dateIssued.year_sort":"2021","dc.date.issued_dt":"2021-01-01T00:00:00Z","dc.date.issued":["2021-01-01"],"dc.date.issued_stored":["2021-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.description.abstract_hl":["Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied by central nervous system damage, widespread immune-mediated demyelination, and axonal damage, involving mainly the optic nerves, spinal cord, and area postrema. The diagnostic capabilities, administration and routing of patients, and therapeutic approaches to this disease need to be improved. During several expert councils held in 2019–2021 in different regions of the Russian Federation, we discussed multiple issues related to various aspects of medical care for patients with NMOSDs. As a result, the experts developed further steps necessary to improve the medical care to these patients: to write and publish clinical guidelines for the diagnosis and treatment of NMOSDs; to consider the possibility of optimizing the NMOSDs diagnostic program including the aquaporin-4 antibodies (AQP4-IgG) testing; to evaluate the implementation of a set of measures aimed at including the corresponding laboratory investigations into the system of state guarantees (together with the institutions of the Ministry of Health of Russia), if there is clinical and economic feasibility; to include the issues of timely NMOSDs evaluation in educational programs initiated by the scientific medical community, in order to raise awareness of primary care neurologists in relation to the clinical and neuroimaging signs of probable NMOSDs; to assess the possibility of introducing routing schemes for patients with NMOSDs at the regional level; to work out a decision on the collection of NMOSDs epidemiological and clinical data in the Russian Federation. © 2021 Ima-Press Publishing House. All rights reserved."],"dc.description.abstract":["Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied by central nervous system damage, widespread immune-mediated demyelination, and axonal damage, involving mainly the optic nerves, spinal cord, and area postrema. The diagnostic capabilities, administration and routing of patients, and therapeutic approaches to this disease need to be improved. During several expert councils held in 2019–2021 in different regions of the Russian Federation, we discussed multiple issues related to various aspects of medical care for patients with NMOSDs. As a result, the experts developed further steps necessary to improve the medical care to these patients: to write and publish clinical guidelines for the diagnosis and treatment of NMOSDs; to consider the possibility of optimizing the NMOSDs diagnostic program including the aquaporin-4 antibodies (AQP4-IgG) testing; to evaluate the implementation of a set of measures aimed at including the corresponding laboratory investigations into the system of state guarantees (together with the institutions of the Ministry of Health of Russia), if there is clinical and economic feasibility; to include the issues of timely NMOSDs evaluation in educational programs initiated by the scientific medical community, in order to raise awareness of primary care neurologists in relation to the clinical and neuroimaging signs of probable NMOSDs; to assess the possibility of introducing routing schemes for patients with NMOSDs at the regional level; to work out a decision on the collection of NMOSDs epidemiological and clinical data in the Russian Federation. © 2021 Ima-Press Publishing House. All rights reserved."],"dc.description.abstract.en":["Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied by central nervous system damage, widespread immune-mediated demyelination, and axonal damage, involving mainly the optic nerves, spinal cord, and area postrema. The diagnostic capabilities, administration and routing of patients, and therapeutic approaches to this disease need to be improved. During several expert councils held in 2019–2021 in different regions of the Russian Federation, we discussed multiple issues related to various aspects of medical care for patients with NMOSDs. As a result, the experts developed further steps necessary to improve the medical care to these patients: to write and publish clinical guidelines for the diagnosis and treatment of NMOSDs; to consider the possibility of optimizing the NMOSDs diagnostic program including the aquaporin-4 antibodies (AQP4-IgG) testing; to evaluate the implementation of a set of measures aimed at including the corresponding laboratory investigations into the system of state guarantees (together with the institutions of the Ministry of Health of Russia), if there is clinical and economic feasibility; to include the issues of timely NMOSDs evaluation in educational programs initiated by the scientific medical community, in order to raise awareness of primary care neurologists in relation to the clinical and neuroimaging signs of probable NMOSDs; to assess the possibility of introducing routing schemes for patients with NMOSDs at the regional level; to work out a decision on the collection of NMOSDs epidemiological and clinical data in the Russian Federation. © 2021 Ima-Press Publishing House. All rights reserved."],"dc.doi":["10.14412/2074-2711-2021-5-140-147"],"dc.identifier.issn":["2074-2711"],"dc.identifier.uri":["http://hdl.handle.net/123456789/6215"],"dc.language.iso":["en"],"dc.language.iso.en":["en"],"dc.publisher":["Ima-Press Publishing House"],"dc.publisher.en":["Ima-Press Publishing House"],"dc.relation.ispartofseries":["Nevrologiya, Neiropsikhiatriya, Psikhosomatika;т. 13 № 5"],"dc.relation.ispartofseries.en":["Nevrologiya, Neiropsikhiatriya, Psikhosomatika;т. 13 № 5"],"subject":["Aquaporin-4","Expert advice","Neuromyelitis optica","Neuromyelitis optica spectrum disorders","Scopus"],"subject_keyword":["Aquaporin-4","Aquaporin-4","Expert advice","Expert advice","Neuromyelitis optica","Neuromyelitis optica","Neuromyelitis optica spectrum disorders","Neuromyelitis optica spectrum disorders","Scopus","Scopus"],"subject_ac":["aquaporin-4\n|||\nAquaporin-4","expert advice\n|||\nExpert advice","neuromyelitis optica\n|||\nNeuromyelitis optica","neuromyelitis optica spectrum disorders\n|||\nNeuromyelitis optica spectrum disorders","scopus\n|||\nScopus"],"subject_tax_0_filter":["aquaporin-4\n|||\nAquaporin-4","expert advice\n|||\nExpert advice","neuromyelitis optica\n|||\nNeuromyelitis optica","neuromyelitis optica spectrum disorders\n|||\nNeuromyelitis optica spectrum disorders","scopus\n|||\nScopus"],"subject_filter":["aquaporin-4\n|||\nAquaporin-4","expert advice\n|||\nExpert advice","neuromyelitis optica\n|||\nNeuromyelitis optica","neuromyelitis optica spectrum disorders\n|||\nNeuromyelitis optica spectrum disorders","scopus\n|||\nScopus"],"dc.subject_mlt":["Aquaporin-4","Expert advice","Neuromyelitis optica","Neuromyelitis optica spectrum disorders","Scopus"],"dc.subject":["Aquaporin-4","Expert advice","Neuromyelitis optica","Neuromyelitis optica spectrum disorders","Scopus"],"dc.subject.en":["Aquaporin-4","Expert advice","Neuromyelitis optica","Neuromyelitis optica spectrum disorders","Scopus"],"title":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"title_keyword":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"title_ac":["consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders\n|||\nConsensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.title_sort":"Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders","dc.title_hl":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.title_mlt":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.title":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.title_stored":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.title.en":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.title.alternative":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.title.alternative.en":["Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders"],"dc.type":["Article"],"dc.type.en":["Article"],"publication_grp":["123456789/6215"],"bi_2_dis_filter":["trushnikova, t.n.\n|||\nTrushnikova, T.N.","kotov, s.v.\n|||\nKotov, S.V.","malkova, n.a.\n|||\nMalkova, N.A.","zakharova, m.n.\n|||\nZakharova, M.N.","brylev, l.v.\n|||\nBrylev, L.V.","simaniv, t.o.\n|||\nSimaniv, T.O.","khachanova, n.v.\n|||\nKhachanova, N.V.","sivertseva, s.a.\n|||\nSivertseva, S.A.","khabirov, f.a.\n|||\nKhabirov, F.A.","boyko, a.n.\n|||\nBoyko, A.N.","bakhtiyarova, k.z.\n|||\nBakhtiyarova, K.Z.","krasnov, v.s.\n|||\nKrasnov, V.S.","kasatkin, d.s.\n|||\nKasatkin, D.S.","totolyan, n.a.\n|||\nTotolyan, N.A.","sokolova, a.a.\n|||\nSokolova, A.A.","korobko, d.s.\n|||\nKorobko, D.S.","popova, e.v.\n|||\nPopova, E.V."],"bi_2_dis_partial":["Popova, E.V.","Kotov, S.V.","Brylev, L.V.","Korobko, D.S.","Krasnov, V.S.","Kasatkin, D.S.","Simaniv, T.O.","Khabirov, F.A.","Khachanova, N.V.","Sivertseva, S.A.","Trushnikova, T.N.","Sokolova, A.A.","Zakharova, M.N.","Malkova, N.A.","Bakhtiyarova, K.Z.","Boyko, A.N.","Totolyan, N.A."],"bi_2_dis_value_filter":["Popova, E.V.","Kotov, S.V.","Brylev, L.V.","Korobko, D.S.","Krasnov, V.S.","Kasatkin, D.S.","Simaniv, T.O.","Khabirov, F.A.","Khachanova, N.V.","Sivertseva, S.A.","Trushnikova, T.N.","Sokolova, A.A.","Zakharova, M.N.","Malkova, N.A.","Bakhtiyarova, K.Z.","Boyko, A.N.","Totolyan, N.A."],"bi_4_dis_filter":["neuromyelitis optica\n|||\nNeuromyelitis optica","aquaporin-4\n|||\nAquaporin-4","expert advice\n|||\nExpert advice","scopus\n|||\nScopus","neuromyelitis optica spectrum disorders\n|||\nNeuromyelitis optica spectrum disorders"],"bi_4_dis_partial":["Aquaporin-4","Scopus","Neuromyelitis optica","Expert advice","Neuromyelitis optica spectrum disorders"],"bi_4_dis_value_filter":["Aquaporin-4","Scopus","Neuromyelitis optica","Expert advice","Neuromyelitis optica spectrum disorders"],"bi_sort_1_sort":"consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders","bi_sort_2_sort":"2021","bi_sort_3_sort":"2021-12-08T11:27:00Z","read":["g0"],"_version_":1718577241359646720},{"SolrIndexer.lastIndexed":"2022-05-05T10:40:59.481Z","search.uniqueid":"2-5757","search.resourcetype":2,"search.resourceid":5757,"handle":"123456789/6662","location":["m195","l691"],"location.comm":["195"],"location.coll":["691"],"withdrawn":"false","discoverable":"true","dc.abstract":["Raynaud syndrome is an angiotrophoneurosis, which is based on an organic lesion of the vascular wall in the form of hypertro phy of the intima and a decrease in their internal diameter. The syndrome is associated with systemic rheumatic diseases, endocrine \nand hematological pathology, and individual infections. Clinical manifestations in the form of transient vasospastic reactions are \ntriggered by cold or psychoemotional stress.\nThe purpose of this study is to generalize the currently available information about the prevailing concepts of development of \nRaynaud syndrome.\nThe material for writing the article was domestic and foreign sources over the past 10 years. At the same time, methods were \nused to collect information about the state of the issue, analyze and systematize the data obtained, search for new theories of the\npathogenesis of the phenomenon, indicating possible promising directions in the study of this issue.\nIt was found that the pathogenesis of Raynaud syndrome is based on neurovegetative and intravascular disorders, disorders of \nneoangiogenesis regulation, changes in vascular reactivity. Pathological processes are caused by the progression of major diseases, \nas well as the action of a number of predisposing factors. Ultimately, this leads to structural changes in the vascular wall and the de velopment of ischemia of adjacent tissues."],"dc.abstract.en":["Raynaud syndrome is an angiotrophoneurosis, which is based on an organic lesion of the vascular wall in the form of hypertro phy of the intima and a decrease in their internal diameter. The syndrome is associated with systemic rheumatic diseases, endocrine \nand hematological pathology, and individual infections. Clinical manifestations in the form of transient vasospastic reactions are \ntriggered by cold or psychoemotional stress.\nThe purpose of this study is to generalize the currently available information about the prevailing concepts of development of \nRaynaud syndrome.\nThe material for writing the article was domestic and foreign sources over the past 10 years. At the same time, methods were \nused to collect information about the state of the issue, analyze and systematize the data obtained, search for new theories of the\npathogenesis of the phenomenon, indicating possible promising directions in the study of this issue.\nIt was found that the pathogenesis of Raynaud syndrome is based on neurovegetative and intravascular disorders, disorders of \nneoangiogenesis regulation, changes in vascular reactivity. Pathological processes are caused by the progression of major diseases, \nas well as the action of a number of predisposing factors. Ultimately, this leads to structural changes in the vascular wall and the de velopment of ischemia of adjacent tissues."],"author":["Карабанова, Л.Н.","Букин, С.В.","Рузмайкин, М.В.","Шамрова, Е.А.","Karabanova, L.N.","Bukin, S.V.","Ruzmaikin, M.V.","Shamrova, E.A."],"author_keyword":["Карабанова, Л.Н.","Букин, С.В.","Рузмайкин, М.В.","Шамрова, Е.А.","Karabanova, L.N.","Bukin, S.V.","Ruzmaikin, M.V.","Shamrova, E.A."],"author_ac":["карабанова, л.н.\n|||\nКарабанова, Л.Н.","букин, с.в.\n|||\nБукин, С.В.","рузмайкин, м.в.\n|||\nРузмайкин, М.В.","шамрова, е.а.\n|||\nШамрова, Е.А.","karabanova, l.n.\n|||\nKarabanova, L.N.","bukin, s.v.\n|||\nBukin, S.V.","ruzmaikin, m.v.\n|||\nRuzmaikin, M.V.","shamrova, e.a.\n|||\nShamrova, E.A."],"author_filter":["карабанова, л.н.\n|||\nКарабанова, Л.Н.","букин, с.в.\n|||\nБукин, С.В.","рузмайкин, м.в.\n|||\nРузмайкин, М.В.","шамрова, е.а.\n|||\nШамрова, Е.А.","karabanova, l.n.\n|||\nKarabanova, L.N.","bukin, s.v.\n|||\nBukin, S.V.","ruzmaikin, m.v.\n|||\nRuzmaikin, M.V.","shamrova, e.a.\n|||\nShamrova, E.A."],"dc.contributor.author_hl":["Карабанова, Л.Н.","Букин, С.В.","Рузмайкин, М.В.","Шамрова, Е.А.","Karabanova, L.N.","Bukin, S.V.","Ruzmaikin, M.V.","Shamrova, E.A."],"dc.contributor.author_mlt":["Карабанова, Л.Н.","Букин, С.В.","Рузмайкин, М.В.","Шамрова, Е.А.","Karabanova, L.N.","Bukin, S.V.","Ruzmaikin, M.V.","Shamrova, E.A."],"dc.contributor.author":["Карабанова, Л.Н.","Букин, С.В.","Рузмайкин, М.В.","Шамрова, Е.А.","Karabanova, L.N.","Bukin, S.V.","Ruzmaikin, M.V.","Shamrova, E.A."],"dc.contributor.author_stored":["Карабанова, Л.Н.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Букин, С.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Рузмайкин, М.В.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Шамрова, Е.А.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","Karabanova, L.N.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Bukin, S.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Ruzmaikin, M.V.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen","Shamrova, E.A.\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.contributor.author.ru_RU":["Карабанова, Л.Н.","Букин, С.В.","Рузмайкин, М.В.","Шамрова, Е.А."],"dc.contributor.author.en":["Karabanova, L.N.","Bukin, S.V.","Ruzmaikin, M.V.","Shamrova, E.A."],"dc.date.accessioned_dt":"2022-05-05T10:39:32Z","dc.date.accessioned":["2022-05-05T10:39:32Z"],"dc.date.available":["2022-05-05T10:39:32Z"],"dateIssued":["2020-01-01"],"dateIssued_keyword":["2020-01-01","2020"],"dateIssued_ac":["2020-01-01\n|||\n2020-01-01","2020"],"dateIssued.year":[2020],"dateIssued.year_sort":"2020","dc.date.issued_dt":"2020-01-01T00:00:00Z","dc.date.issued":["2020-01-01"],"dc.date.issued_stored":["2020-01-01\n|||\nnull\n|||\nnull\n|||\nnull\n|||\n"],"dc.description.abstract_hl":["Синдром Рейно представляет собой ангиотрофоневроз, в основе которого лежит органическое поражение стенки сосу дов в виде гипертрофии интимы и уменьшения их внутреннего диаметра. Синдром ассоциируется с системными ревмати ческими заболеваниями, эндокринной и гематологической патологиями, отдельными инфекциями. Клинические проявле ния в виде преходящих вазоспастических реакций возникают при воздействии холода или психоэмоционального перена пряжения. \nЦелью данного исследования является обобщение имеющейся в настоящее время информации о преобладающих кон цепциях развития синдрома Рейно. \nМатериал и методы. Материалом для написания статьи послужили отечественные и зарубежные источники послед них 10 лет. При этом были использованы методы сбора информации о состоянии вопроса, анализа и систематизации полу ченных данных, поиска новых теорий патогенеза феномена с указанием возможных перспективных направлений в изуче нии этого вопроса.\nРезультаты. Выявлено, что в основе патогенеза синдрома Рейно лежат нейровегетативные и внутрисосудистые нару шения, расстройства регуляции неоангиогенеза, изменения реактивности сосудов. Патологические процессы обусловлены \nпрогрессированием основных заболеваний, а также действием ряда предрасполагающих факторов. В конечном итоге это \nприводит к структурным перестройкам сосудистой стенки и развитию ишемии прилежащих тканей."],"dc.description.abstract":["Синдром Рейно представляет собой ангиотрофоневроз, в основе которого лежит органическое поражение стенки сосу дов в виде гипертрофии интимы и уменьшения их внутреннего диаметра. Синдром ассоциируется с системными ревмати ческими заболеваниями, эндокринной и гематологической патологиями, отдельными инфекциями. Клинические проявле ния в виде преходящих вазоспастических реакций возникают при воздействии холода или психоэмоционального перена пряжения. \nЦелью данного исследования является обобщение имеющейся в настоящее время информации о преобладающих кон цепциях развития синдрома Рейно. \nМатериал и методы. Материалом для написания статьи послужили отечественные и зарубежные источники послед них 10 лет. При этом были использованы методы сбора информации о состоянии вопроса, анализа и систематизации полу ченных данных, поиска новых теорий патогенеза феномена с указанием возможных перспективных направлений в изуче нии этого вопроса.\nРезультаты. Выявлено, что в основе патогенеза синдрома Рейно лежат нейровегетативные и внутрисосудистые нару шения, расстройства регуляции неоангиогенеза, изменения реактивности сосудов. Патологические процессы обусловлены \nпрогрессированием основных заболеваний, а также действием ряда предрасполагающих факторов. В конечном итоге это \nприводит к структурным перестройкам сосудистой стенки и развитию ишемии прилежащих тканей."],"dc.description.abstract.ru_RU":["Синдром Рейно представляет собой ангиотрофоневроз, в основе которого лежит органическое поражение стенки сосу дов в виде гипертрофии интимы и уменьшения их внутреннего диаметра. Синдром ассоциируется с системными ревмати ческими заболеваниями, эндокринной и гематологической патологиями, отдельными инфекциями. Клинические проявле ния в виде преходящих вазоспастических реакций возникают при воздействии холода или психоэмоционального перена пряжения. \nЦелью данного исследования является обобщение имеющейся в настоящее время информации о преобладающих кон цепциях развития синдрома Рейно. \nМатериал и методы. Материалом для написания статьи послужили отечественные и зарубежные источники послед них 10 лет. При этом были использованы методы сбора информации о состоянии вопроса, анализа и систематизации полу ченных данных, поиска новых теорий патогенеза феномена с указанием возможных перспективных направлений в изуче нии этого вопроса.\nРезультаты. Выявлено, что в основе патогенеза синдрома Рейно лежат нейровегетативные и внутрисосудистые нару шения, расстройства регуляции неоангиогенеза, изменения реактивности сосудов. Патологические процессы обусловлены \nпрогрессированием основных заболеваний, а также действием ряда предрасполагающих факторов. В конечном итоге это \nприводит к структурным перестройкам сосудистой стенки и развитию ишемии прилежащих тканей."],"dc.identifier.issn":["1999-6209"],"dc.identifier.other":["УДК 616.8-009.865"],"dc.identifier.other.ru_RU":["УДК 616.8-009.865"],"dc.identifier.uri":["http://hdl.handle.net/123456789/6662"],"dc.publisher":["Издательство \"ФГБОУ ВО БГМУ Минздрава России\""],"dc.publisher.ru_RU":["Издательство \"ФГБОУ ВО БГМУ Минздрава России\""],"dc.relation.ispartofseries":["Медицинский вестник Башкортостана;т. 15 № 2"],"dc.relation.ispartofseries.ru_RU":["Медицинский вестник Башкортостана;т. 15 № 2"],"subject":["синдром Рейно","патогенез","внутрисосудистые нарушения","эндотелий","нейровегетативные нарушения","вазоспазм","Raynaud syndrome","pathogenesis","intravascular disorders","endothelium","neurovegetative disorders","vasospasm"],"subject_keyword":["синдром Рейно","синдром Рейно","патогенез","патогенез","внутрисосудистые нарушения","внутрисосудистые нарушения","эндотелий","эндотелий","нейровегетативные нарушения","нейровегетативные нарушения","вазоспазм","вазоспазм","Raynaud syndrome","Raynaud syndrome","pathogenesis","pathogenesis","intravascular disorders","intravascular disorders","endothelium","endothelium","neurovegetative disorders","neurovegetative disorders","vasospasm","vasospasm"],"subject_ac":["синдром рейно\n|||\nсиндром Рейно","патогенез\n|||\nпатогенез","внутрисосудистые нарушения\n|||\nвнутрисосудистые нарушения","эндотелий\n|||\nэндотелий","нейровегетативные нарушения\n|||\nнейровегетативные нарушения","вазоспазм\n|||\nвазоспазм","raynaud syndrome\n|||\nRaynaud syndrome","pathogenesis\n|||\npathogenesis","intravascular disorders\n|||\nintravascular disorders","endothelium\n|||\nendothelium","neurovegetative disorders\n|||\nneurovegetative disorders","vasospasm\n|||\nvasospasm"],"subject_tax_0_filter":["синдром рейно\n|||\nсиндром Рейно","патогенез\n|||\nпатогенез","внутрисосудистые нарушения\n|||\nвнутрисосудистые нарушения","эндотелий\n|||\nэндотелий","нейровегетативные нарушения\n|||\nнейровегетативные нарушения","вазоспазм\n|||\nвазоспазм","raynaud syndrome\n|||\nRaynaud syndrome","pathogenesis\n|||\npathogenesis","intravascular disorders\n|||\nintravascular disorders","endothelium\n|||\nendothelium","neurovegetative disorders\n|||\nneurovegetative disorders","vasospasm\n|||\nvasospasm"],"subject_filter":["синдром рейно\n|||\nсиндром Рейно","патогенез\n|||\nпатогенез","внутрисосудистые нарушения\n|||\nвнутрисосудистые нарушения","эндотелий\n|||\nэндотелий","нейровегетативные нарушения\n|||\nнейровегетативные нарушения","вазоспазм\n|||\nвазоспазм","raynaud syndrome\n|||\nRaynaud syndrome","pathogenesis\n|||\npathogenesis","intravascular disorders\n|||\nintravascular disorders","endothelium\n|||\nendothelium","neurovegetative disorders\n|||\nneurovegetative disorders","vasospasm\n|||\nvasospasm"],"dc.subject_mlt":["синдром Рейно","патогенез","внутрисосудистые нарушения","эндотелий","нейровегетативные нарушения","вазоспазм","Raynaud syndrome","pathogenesis","intravascular disorders","endothelium","neurovegetative disorders","vasospasm"],"dc.subject":["синдром Рейно","патогенез","внутрисосудистые нарушения","эндотелий","нейровегетативные нарушения","вазоспазм","Raynaud syndrome","pathogenesis","intravascular disorders","endothelium","neurovegetative disorders","vasospasm"],"dc.subject.ru_RU":["синдром Рейно","патогенез","внутрисосудистые нарушения","эндотелий","нейровегетативные нарушения","вазоспазм"],"dc.subject.en":["Raynaud syndrome","pathogenesis","intravascular disorders","endothelium","neurovegetative disorders","vasospasm"],"title":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"title_keyword":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"title_ac":["механизм развития и звенья патогенеза синдрома рейно\n|||\nМЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","mechanism of development and links of pathogenesis of raynaud syndrome\n|||\nMECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"dc.title_sort":"МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","dc.title_hl":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"dc.title_mlt":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"dc.title":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО","MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"dc.title_stored":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nru_RU","MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME\n|||\nnull\n|||\nnull\n|||\nnull\n|||\nen"],"dc.title.ru_RU":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО"],"dc.title.en":["MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"dc.title.alternative":["MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME","МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО"],"dc.title.alternative.en":["MECHANISM OF DEVELOPMENT AND LINKS OF PATHOGENESIS OF RAYNAUD SYNDROME"],"dc.title.alternative.ru_RU":["МЕХАНИЗМ РАЗВИТИЯ И ЗВЕНЬЯ ПАТОГЕНЕЗА СИНДРОМА РЕЙНО"],"dc.type":["Article"],"dc.type.ru_RU":["Article"],"publication_grp":["123456789/6662"],"bi_2_dis_filter":["рузмайкин, м.в.\n|||\nРузмайкин, М.В.","karabanova, l.n.\n|||\nKarabanova, L.N.","ruzmaikin, m.v.\n|||\nRuzmaikin, M.V.","bukin, s.v.\n|||\nBukin, S.V.","shamrova, e.a.\n|||\nShamrova, E.A.","карабанова, л.н.\n|||\nКарабанова, Л.Н.","букин, с.в.\n|||\nБукин, С.В.","шамрова, е.а.\n|||\nШамрова, Е.А."],"bi_2_dis_partial":["Карабанова, Л.Н.","Ruzmaikin, M.V.","Shamrova, E.A.","Букин, С.В.","Karabanova, L.N.","Bukin, S.V.","Шамрова, Е.А.","Рузмайкин, М.В."],"bi_2_dis_value_filter":["Карабанова, Л.Н.","Ruzmaikin, M.V.","Shamrova, E.A.","Букин, С.В.","Karabanova, L.N.","Bukin, S.V.","Шамрова, Е.А.","Рузмайкин, М.В."],"bi_4_dis_filter":["vasospasm\n|||\nvasospasm","raynaud syndrome\n|||\nRaynaud syndrome","pathogenesis\n|||\npathogenesis","нейровегетативные нарушения\n|||\nнейровегетативные нарушения","вазоспазм\n|||\nвазоспазм","endothelium\n|||\nendothelium","neurovegetative disorders\n|||\nneurovegetative disorders","эндотелий\n|||\nэндотелий","патогенез\n|||\nпатогенез","intravascular disorders\n|||\nintravascular disorders","синдром рейно\n|||\nсиндром Рейно","внутрисосудистые нарушения\n|||\nвнутрисосудистые нарушения"],"bi_4_dis_partial":["Raynaud syndrome","pathogenesis","intravascular disorders","endothelium","синдром Рейно","эндотелий","вазоспазм","neurovegetative disorders","vasospasm","патогенез","внутрисосудистые нарушения","нейровегетативные нарушения"],"bi_4_dis_value_filter":["Raynaud syndrome","pathogenesis","intravascular disorders","endothelium","синдром Рейно","эндотелий","вазоспазм","neurovegetative disorders","vasospasm","патогенез","внутрисосудистые нарушения","нейровегетативные нарушения"],"bi_sort_1_sort":"механизм развития и звенья патогенеза синдрома рейно","bi_sort_2_sort":"2020","bi_sort_3_sort":"2022-05-05T10:39:32Z","read":["g0"],"_version_":1731982534368034816}]},"facet_counts":{"facet_queries":{},"facet_fields":{},"facet_dates":{},"facet_ranges":{},"facet_intervals":{}},"highlighting":{"2-7173":{"dc.title.en":["Poststroke Asthenic Disorder"],"dc.title":["Poststroke Asthenic Disorder"],"dc.title_hl":["Poststroke Asthenic Disorder"],"dc.title_mlt":["Poststroke Asthenic Disorder"],"dc.title.alternative.en":["Poststroke Asthenic Disorder"],"title":["Poststroke Asthenic Disorder"],"dc.abstract.en":["Asthenic disorders are seen in approximately half of poststroke patients. The mechanisms underlying"],"dc.title.alternative":["Poststroke Asthenic Disorder"],"dc.abstract":["Asthenic disorders are seen in approximately half of poststroke patients. The mechanisms underlying"]},"2-8043":{"dc.citation.en":[" of childhood obesity and mental retardation. Eur J Paediatr Neurol. 2000;4(2):63–7. DOI: 10.1053/ejpn.2000.0264"],"dc.citation.ru":[" of childhood obesity and mental retardation. Eur J Paediatr Neurol. 2000;4(2):63–7. DOI: 10.1053/ejpn.2000.0264"],"dc.abstract.en":[" and poorly understood disorder. This condition is characterized by diffuse proliferation of adipose tissue"],"dc.citation":[" of childhood obesity and mental retardation. Eur J Paediatr Neurol. 2000;4(2):63–7. DOI: 10.1053/ejpn.2000.0264"],"dc.abstract":[" and poorly understood disorder. This condition is characterized by diffuse proliferation of adipose tissue"]},"2-4548":{"dc.abstract.en":[" as the development of borderline mental disorders and stress. Any non-specific reactions can be accompanied"],"dc.abstract":[" as the development of borderline mental disorders and stress. Any non-specific reactions can be accompanied"]},"2-7042":{"dc.title.en":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.title":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.title_hl":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.title_mlt":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.title.alternative.en":["Cognitive disorders in amyotrophic lateral sclerosis"],"title":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.abstract.en":["Cognitive disorders (CD) are observed in more than half of patients with amyotrophic lateral"],"dc.title.alternative":["Cognitive disorders in amyotrophic lateral sclerosis"],"dc.abstract":["Cognitive disorders (CD) are observed in more than half of patients with amyotrophic lateral"]},"2-6206":{"dc.title.en":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title_hl":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.title_mlt":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"bi_4_dis_partial":["hemodynamic disorder"],"dc.subject.en":["hemodynamic disorder"],"dc.title.alternative.en":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"title":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.subject":["hemodynamic disorder"],"dc.subject_mlt":["hemodynamic disorder"],"dc.abstract.en":["Purpose: to identify the features of hemodynamic disorders in women with atrophic form of chronic"],"subject":["hemodynamic disorder"],"dc.title.alternative":["FEATURES OF HEMODYNAMIC DISORDERS IN ATROPHIC FORM OF CHRONIC ENDOMETRITIS"],"dc.abstract":["Purpose: to identify the features of hemodynamic disorders in women with atrophic form of chronic"]},"2-7265":{"dc.description.abstract":[" in autism spectrum disorders and depression, as well as in Alzheimer’s disease, Parkinson’s disease"],"bi_4_dis_partial":["psychoemotional disorders"],"dc.description.abstract.en":[" in autism spectrum disorders and depression, as well as in Alzheimer’s disease, Parkinson’s disease"],"dc.subject.en":["psychoemotional disorders"],"dc.description.abstract_hl":[" in autism spectrum disorders and depression, as well as in Alzheimer’s disease, Parkinson’s disease"],"dc.subject":["psychoemotional disorders"],"dc.subject_mlt":["psychoemotional disorders"],"subject":["psychoemotional disorders"]},"2-2538":{"dc.description.abstract":["This review presents the most recent data of worldwide research on anxiety and depressive disorders"],"bi_4_dis_partial":["cognitive disorders"],"dc.description.abstract.en":["This review presents the most recent data of worldwide research on anxiety and depressive disorders"],"dc.subject.en":["cognitive disorders"],"dc.title.alternative.en":["ANXIETY AND DEPRESSIVE DISORDERS IN PARKINSON’S DISEASE"],"dc.description.abstract_hl":["This review presents the most recent data of worldwide research on anxiety and depressive disorders"],"dc.subject":["cognitive disorders"],"dc.subject_mlt":["cognitive disorders"],"subject":["cognitive disorders"],"dc.title.alternative":["ANXIETY AND DEPRESSIVE DISORDERS IN PARKINSON’S DISEASE"]},"2-4604":{"dc.description.abstract":[" eligibility. Methods: International online survey of neurologists/mental health professionals from Argentina"],"dc.description.abstract.en":[" eligibility. Methods: International online survey of neurologists/mental health professionals from Argentina"],"dc.description.abstract_hl":[" eligibility. Methods: International online survey of neurologists/mental health professionals from Argentina"]},"2-5305":{"dc.title.en":[" optica spectrum disorders"],"dc.description.abstract":["Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied"],"dc.title":[" optica spectrum disorders"],"dc.title_hl":[" optica spectrum disorders"],"dc.title_mlt":[" optica spectrum disorders"],"bi_4_dis_partial":["Neuromyelitis optica spectrum disorders"],"dc.description.abstract.en":["Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied"],"dc.subject.en":["Neuromyelitis optica spectrum disorders"],"dc.title.alternative.en":[" optica spectrum disorders"],"title":[" optica spectrum disorders"],"dc.description.abstract_hl":["Neuromyelitis optica spectrum disorders (NMOSDs) are autoimmune inflammatory disorders accompanied"],"dc.subject":["Neuromyelitis optica spectrum disorders"],"dc.subject_mlt":["Neuromyelitis optica spectrum disorders"],"subject":["Neuromyelitis optica spectrum disorders"],"dc.title.alternative":[" optica spectrum disorders"]},"2-5757":{"bi_4_dis_partial":["intravascular disorders"],"dc.subject.en":["intravascular disorders"],"dc.subject":["intravascular disorders"],"dc.subject_mlt":["intravascular disorders"],"dc.abstract.en":[".\nIt was found that the pathogenesis of Raynaud syndrome is based on neurovegetative and intravascular disorders"],"subject":["intravascular disorders"],"dc.abstract":[".\nIt was found that the pathogenesis of Raynaud syndrome is based on neurovegetative and intravascular disorders"]}}} -->